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ABSTRACT
CLINICAL OUTCOMES INVOLVING
THE USE OF EXTRACORPOREAL MAGNETIC INNERVATION
IN THE TREATMENT OF URINARY INCONTINENCE
by
KATHY E. DAVIS
Urinary incontinence affects approximately 25 million Americans, significantly
diminishing their function and quality of life. It is estimated that 50% of all women will
experience some form of urinary incontinence in their lifetime. Although women are
disproportionately affected by urinary incontinence, 69% of men who have undergone
prostatectomy also report post-surgical incontinence.
Extracorporeal Magnetic Innervation (ExMI) is a novel conservative approach to
the treatment of urinary incontinence. As a patient sits fully clothed on a chair, an
electromagnet delivers a timed magnetic field that penetrates the pelvic floor, inducing a
nerve impulse that prompts contractions of the muscles of the pelvic floor. When the
magnet is switched off, the muscles relax. This forced, passive exercise of the pelvic
floor muscles serves to build endurance and strengthen the muscles supporting the
bladder during times of physical stress such as coughing, laughing or running.
This study is a descriptive, retrospective analysis of data collected from a
specialty continence center within a major Atlanta metropolitan outpatient facility. The
records for all patients who received ExMI from 2000 to 2012 were reviewed. Of the 43
patients who had received ExMI, 35 met study inclusion criteria. Eight patients were
eliminated from the study. Four of these patients experienced ExMI benefits for
vi

conditions unrelated to urinary incontinence and are discussed. Data were analyzed using
descriptive and inferential statistics. .
The majority of the patients were women (n=26, 74%); most patients had stress
urinary incontinence (n=16, 46%) or mixed urinary incontinence (n=12, 34%). The
patient outcome was determined by comparing the pad usage before treatment and at the
end of treatment (16 weeks). The average number of pads used daily was significantly
reduced to 1.6 3 + 0.94 (p<.0001). Treatment with ExMI for urinary incontinence was
briefly popular in the United States shortly after it was introduced. Although ExMI is
used extensively across Europe and Asia, very few studies on the efficacy of ExMI
appear in the literature. These results will add to this body of knowledge.
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CHAPTER I
INTRODUCTION
Urinary incontinence is defined as the involuntary loss of urine from the bladder
(Craven & Hirnle, 2003). According to Sakamoto, Sharma, and Wheeler (2007) this is a
problem that affects approximately 25 million Americans. Anatomical differences,
trauma that can occur during childbirth and hormonal changes brought about by
menopause predispose women to be disproportionately affected by urinary incontinence
more than men (Katz, 2009). It is estimated that 50% of all women will experience some
form of urinary incontinence in their lifetime (Melville, Katon, Delaney, & Newton,
2005; Huang et al., 2006). The overall prevalence of urinary incontinence in ambulatory
men is reported at around 30% (Smoger, Felice, & Kloecker, 2000). Of men who have
undergone radical prostatectomy, up to 69% have reported some post-surgical
incontinence (Hollenbeck et al., 2002). It is of interest that men report more social
limitation and more frustration and shame from urinary incontinence than women
(Lagro-Janssen, Hilkens, Klaasen, & Teunissen, 2008).
It is difficult to predict the financial cost of urinary incontinence with any
precision since most projections fail to take into consideration inflation and increases in
the cost of medical care and supplies, however, the yearly expense of incontinence care is
estimated at over $27 billion. This expense is attributed to catheters, containment
devices, laundry services, medical care for infections, injuries sustained in falls,
prolonged hospital stays, and the indirect costs of lost time from work for patients or
1
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caregivers (Kerr, 2005; Landefeld, et al., 2008). In addition to the high financial cost of
urinary incontinence, there is personal degradation from the negative physical, social, and
emotional impact of this dysfunction.
Urinary incontinence is categorized according to etiology and is commonly
referred to as stress, urge, mixed, reflex, overflow, or functional incontinence. Stress and
mixed urinary incontinence (symptoms of both stress and urge) predominate (Diokno et
al., 2003; Kristensen, Eldoma, Williamson, Wood, & Mainprize, 2010). Treatment is
based on the type of incontinence the patient is experiencing and includes selfmanagement strategies, behavioral therapies, pelvic floor rehabilitation, medications and
surgery.
Problem Statement
Although therapies exist, many people continue to live with the physical and
psychological distress of urinary incontinence. Control over urination is learned in early
childhood, so loss of this control in adulthood is a demoralizing condition that has been
described as “a disfigurement of self” (Nahon, Dorey, Waddington, & Adams, 2009).
The reasons for living with urinary incontinence are varied. Hagglund & Wadensten
(2007) suggest that living with the shame of incontinence and fear of humiliation prevent
some patients from seeking care for incontinence. Too embarrassed to discuss this
problem with their nurse or doctor, they try to manage the incontinence on their own.
Some patients think that being incontinent is to be expected with aging, and not viewed
as abnormal (Newman, 1998) while others do not think that there is any effective
treatment (MacKay & Hemmett, 2001). According to Newman (1998) most women will
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wait approximately three years before seeking medical care for urinary incontinence,
whereas men will seek help within six months.
Urinary incontinence has a negative impact on emotional health and self-esteem
(Fultz & Herzog, 2001; MacKay & Hemmett, 2001) and significantly diminishes
function and quality of life (Melville, Katon, Delaney, & Newton, 2005). Patients have
reported sleep disturbances related to eneuretic episodes. Complaints of interrupted sleep
resulting in next day exhaustion, or no longer sleeping with their partner so that their
partner’s sleep is not disturbed are commonly expressed (Palmer, Fogarty, Somerfield, &
Powel, 2003). These patients experience a higher incidence of depression and lower selfesteem that they believe negatively affects their work performance and social activities
(Yeung et al., 2003).
Incontinence is frequently cited as being a barrier to physical activity. Brown &
Miller (2001) examined results from the Australian Longitudinal Study on Women’s
Health Survey (ALSWH) to ascertain both the prevalence of urinary incontinence and
whether women perceived the incontinence to be a barrier to physical activity. The
ALSWH has been collecting information on physical, psychological and social aspects of
women’s health since 1996. At that time over 40,000 women were included in the
baseline study. Data was collected from young (18-23), middle age (45-50), and older
women (79-75) with regard to their experience of urinary incontinence. All age groups
reported episodes of urinary incontinence. In 1999 a follow up survey to examine the
relationship between incontinence and physical activity was sent to 1500 women who had
participated in the baseline survey. Over 1000 women participated in the follow-up
survey. Overall, 89% of respondents reported leaking urine when coughing or laughing,
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and more than 40% reported leaking when engaged in physical exercise. These women
described a variety of management strategies to avoid or minimize incontinence while
participating in any sort of physical exercise. More than one third of middle aged women
and one quarter of older women completely avoided physical activity due to their
incontinence. Similar self-imposed modifications and restrictions to recreation and
physical functions such as walking, running, lifting, and carrying have also been reported
in the literature (Brocklehurst, 1993; Hagglund, Walker-Engstrom, Larsson, & Leppert,
2004; St. John, Wallis, Griffiths, & McKenzie, 2010).
Living with incontinence on a daily basis, wearing sanitary pads or diapers,
choosing clothing that can conceal a leak, and frequent washing to prevent odors can all
negatively affect a person’s self-image and sexuality. Incontinence has been shown to
cause a loss of libido and sexual dysfunction that can result in barriers to healthy
relationships (Katz, 2009). All the work that goes into daily management of urinary
incontinence as well as the involuntary loss of urine during sexual intercourse have been
cited as having a major negative impact on sexual relations (O’Connell, Baker, & Munro,
2007). In a study of 166 men who had undergone prostatectomy, 114 (69%) reported
problems with urinary incontinence, management of urinary incontinence and coping.
Patients found the social limitations of urinary incontinence to be the most difficult.
These men voiced their reluctance to become sexually involved in the future for fear that
their incontinence would be discovered (Palmer, Fogarty, Somerfield, & Powel, 2003).
Compounding the financial costs and psychological toll, there are other risks
associated with urinary incontinence. Incontinence-associated dermatitis (IAD) of the
perineum has been reported in up to 50% of persons who suffer with incontinence.
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Inflammation of the skin with erythema, edema and erosion of superficial layers of skin
is characteristic of IAD. In reviewing the existing literature, several factors were found
to contribute to the development of IAD including the patient’s age, general health,
nutrition, friction/shear, volume and frequency of incontinence (Gray et al, 2007;
Langemo, Hanson, Hunter, Thompson, & Oh, 2011). These skin injuries add to the
physical misery as well as the economic burden.
Falls and resultant injuries are serious concerns for persons with urinary
incontinence. They threaten independence and are the leading cause of death in persons
over the age of 65 (Brady & Lamb, 2008). Byles, Millar, Sibbritt, & Chiarelli (2009)
examined ALSWH data and found a positive correlation between the incidence of falls in
older women with incontinence. Hasegawa, Masafumi, & Iguchi (2009) conducted a
study with over one thousand participants, both men and women. Their study also
indicated that recurrent and injurious falls have been associated with urinary incontinence
and are prevalent in long-term care facilities among the elderly who are frail and who
have comorbid conditions including diabetes, cancer, hypertension, osteoporosis and
dementia.
Clearly urinary incontinence is a major healthcare problem that negatively affects
millions of people. The physical discomfort and potential risk of injury related to
incontinence is compounded by the personal and social burden that accompanies it.
Urinary incontinence also poses a challenge to healthcare professionals and drains
available resources. First line treatment for urinary incontinence includes the use of pads,
behavioral modification and conservative, self-management strategies such as fluid, diet,
and bowel management. Patients may also be taught how to perform Kegel exercises to
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strengthen the pelvic floor. If these techniques fail to provide the desired continence,
more aggressive therapies, including pessaries, biofeedback, electrical stimulation,
medications, the injection of bulking agents or surgery may be the next step. There is
another treatment modality that uses pulsed electromagnetic fields to force pelvic muscle
contraction. Extracorporeal magnetic innervation (ExMI), the use of pulsed
electromagnetic fields in the treatment of urinary incontinence, is a non-invasive,
conservative treatment that has been available for more than a decade, but there is little in
the literature regarding the effectiveness of this treatment. This study will add to the
body of knowledge of the effectiveness of ExMI.
Purpose of the Study
The purpose of this study is to describe clinical outcomes for patients who were
treated with ExMI for stress, urge and mixed urinary incontinence. Clinical outcomes are
the end results of treatment effectiveness, length of time this effectiveness lasts, and any
benefits unrelated to urinary incontinence. The literature has shown that electromagnetic
pulse therapy can have other beneficial effects. Although ExMI is intended for the
treatment of urinary incontinence, end results unrelated to urinary incontinence will be
included in clinical outcomes.
Specific objectives of the study
1. Examine the differences in selected demographics (age in years, gender, race,
weight in pounds) and relationship among health behaviors (dietary/fluid
management, bowel management, Kegel exercises), medications (diuretics,
central nervous system [CNS] depressants, hormones, anticholinergics,
antihistamines, others as appropriate to bladder function), substance use
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(tobacco, caffeine, alcohol), physical findings (cystocele, rectocele, uterine
prolapse, vaginal/rectal tone/grip), medical history (length of incontinence,
pelvic surgery, cardiovascular disease, hypertension, diabetes, neurologic
disorders, stroke, COPD/asthma, bladder/kidney infections,
pelvic/abdominal/back pain, pregnancies, methods of delivery, number of
wetting episodes and number of pads used per day prior to treatment),
between patients with stress urge, and mixed urinary incontinence.
2. Explore the relationship of selected demographics (age in years, gender, race,
weight in pounds) and health behaviors (dietary/fluid management, bowel
management, Kegel exercises), medications (diuretics, central nervous system
[CNS] depressants, hormones, anticholinergics, antihistamines, others as
appropriate to bladder function), substance use (tobacco, caffeine, alcohol),
physical findings (cystocele, rectocele, uterine prolapse, vaginal/rectal
tone/grip), medical history (length of incontinence, pelvic surgery,
cardiovascular disease, hypertension, diabetes, neurologic disorders, stroke,
COPD/asthma, bladder/kidney infections, pelvic/abdominal/back pain,
pregnancies, methods of delivery, number of wetting episodes and number of
pads used per day prior to treatment), and post-treatment wetting episodes
following ExMI treatment for urinary incontinence.
3. Explore the relationship of selected demographics (age in years, gender, race,
weight in pounds) and health behaviors (dietary/fluid management, bowel
management, Kegel exercises), medications (diuretics, central nervous system
[CNS] depressants, hormones, anticholinergics, antihistamines, others as
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appropriate to bladder function), substance use (tobacco, caffeine, alcohol),
physical findings (cystocele, rectocele, uterine prolapse, vaginal/rectal
tone/grip), medical history (length of incontinence, pelvic surgery,
cardiovascular disease, hypertension, diabetes, neurologic disorders, stroke,
COPD/asthma, bladder/kidney infections, pelvic/abdominal/back pain,
pregnancies, methods of delivery, number of wetting episodes and number of
pads used per day prior to treatment), and post-treatment pad usage following
ExMI treatment for urinary incontinence.
4. Describe the patients who experienced relapse in urinary incontinence after
treatment with ExMI and any benefits received unrelated to reduction of
urinary incontinence.
5. Examine the differences in selected demographics (age in years, gender, race,
weight in pounds) and health behaviors (dietary/fluid management, bowel
management, Kegel exercises), medications (diuretics, central nervous system
[CNS] depressants, hormones, anticholinergics, antihistamines, others as
appropriate to bladder function), substance use (tobacco, caffeine, alcohol),
physical findings (cystocele, rectocele, uterine prolapse, vaginal/rectal
tone/grip), medical history (length of incontinence, pelvic surgery,
cardiovascular disease, hypertension, diabetes, neurologic disorders, stroke,
COPD/asthma, bladder/kidney infections, pelvic/abdominal/back pain,
pregnancies, methods of delivery, number of wetting episodes and number of
pads used per day prior to treatment), wetting episodes, and pad usage
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between patients who do not relapse following ExMI treatment and those who
do.
Research objectives were modified due to sample size limitations and available
information that was documented in the archived records. The revised research
objectives are as follows and will be referred to in the following chapters.
1. Examine the differences in selected demographics (age in years, gender,
weight in pounds) and relationship among health behaviors (dietary/fluid
management, bowel management), medications (diuretics, central nervous
system [CNS] depressants, hormones, anticholinergics, antihistamines, others
as appropriate to bladder function), physical findings (cystocele, rectocele,
uterine prolapse, vaginal/rectal tone/grip), medical history (length of
incontinence, pelvic surgery, cardiovascular disease, hypertension, diabetes,
neurologic disorders, stroke, COPD/asthma, bladder/kidney infections,
pelvic/abdominal/back pain, pregnancies, methods of delivery, and number of
pads used per day prior to treatment), between patients with stress, urge, and
mixed urinary incontinence.
2. Explore the relationship of selected demographics (age in years, gender,
weight in pounds) and health behaviors (dietary/fluid management, bowel
management), medications (diuretics, central nervous system [CNS]
depressants, hormones, anticholinergics, antihistamines, others as appropriate
to bladder function), physical findings (cystocele, rectocele, uterine prolapse,
vaginal/rectal tone/grip), medical history (length of incontinence, pelvic
surgery, cardiovascular disease, hypertension, diabetes, neurologic disorders,
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stroke, COPD/asthma, bladder/kidney infections, pelvic/abdominal/back pain,
pregnancies, methods of delivery, and number of pads used per day prior to
treatment), and post-treatment pad usage following ExMI treatment for
urinary incontinence.
3. Describe the patients who returned for additional ExMI treatments.
4. Describe any benefits received unrelated to reduction of urinary incontinence.
Conceptual Framework
The framework for this study is based on scientific concepts including the
physiology of micturition and the physics of pulsed electromagnetic fields.
Physiology of Micturition
Normal micturition is a highly synchronized act involving both involuntary and
voluntary mechanisms. There are storage and evacuation phases that must be
coordinated between the bladder and urinary sphincters so that continence is maintained.
During the storage phase, sympathetic stimulation keeps the detrusor muscle of the
bladder relaxed, and the internal urethral sphincter contracted. As the bladder fills with
urine and the volume reaches about 200 mL, stretch receptors in the bladder stimulate the
spinal cord at the level of S2-S4. This information is relayed to the pontine micturition
center in the brain which becomes activated resulting in the urge to void. Voiding occurs
when parasympathetic stimulation relaxes the internal urethra, and causes the detrusor
muscle to contract. Sympathetic nervous system stimulation closes the internal urethral
sphincter and at the same time allows for conscious control over voiding through
voluntary contraction of the external urethral sphincter. When the time and place are
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appropriate, conscious voluntary relaxation of the external sphincter is allowed so that the
bladder can empty (Athwal et al., 2001; Blok, Sturms, & Holstege, 1998; Porth, 2011).
Types of Urinary Incontinence
Stress Incontinence. Pelvic floor muscle support is critical to the maintenance of
continence. The levator ani is the largest and most important muscle of the pelvic floor.
It forms a sling that supports and holds the pelvic organs in place as well as helps to
maintain voluntary control over urination in coordination with the parasympathetic and
sympathetic nervous systems, bladder, and urethral sphincters (Moore & Dalley, 1999).
Overstretched and ruptured connective tissue, muscle, and nerve fibers result in loss of
muscle tone and result in poor support of the bladder and urinary sphincter (Baessler &
Schuessler, 2003). Neuromuscular and connective tissue damage from overstretching has
been associated with vaginal delivery. A sudden increase in intra-abdominal pressure
such as in coughing or sneezing, or physical activity such as lifting or running can result
in the involuntary loss of urine known as stress incontinence (Keyock & Newman, 2011).
Vaginal and periurethral tissues are sensitive to the effects of circulating estrogen.
It is believed that estrogen increases urethral closure pressure which helps to maintain
continence (Robinson & Cardozo, 2003). Low estrogen levels just prior to menstruation
and after menopause have been linked to lowered urethral closure pressure and weakened
sphincter muscles (Palmieri et al., 2007). When urethral pressure is lowered, the chance
of leakage with a sudden rise in intra-abdominal pressure increases. Post menopause, as
the urethral lining thins, the structural support for the bladder is reduced, again,
increasing the chance for stress incontinence to occur.
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In patients who smoke, research suggests there may be a link between
incontinence and the synthesis of collagen (Bottomley, 2000; Bump & McClish, 1992).
Collagen in connective tissue is essential for providing pelvic floor support and lack of
adequate pelvic floor support may be in part due to abnormal collagen synthesis (Wong,
Harmanli, Agar, Dandolu, & Grody, 2003). The periurethral tissues are comprised mainly
of type I and type III collagens. Smoking has been shown to decrease biosynthesis of
these collagens (Knuutinen et al., 2002). Compounding this problem, the inflammation of
the respiratory passages from smoking results in a chronic cough. The pairing of poor
pelvic floor support and sudden increase in intra-abdominal pressure from coughing
increases the risk of urinary incontinence.
Although associated with damage incurred during childbirth or lack of estrogen,
stress incontinence is not strictly a woman’s disorder. Approximately half of all men who
undergo radical prostatectomy experience urinary incontinence due to damage to the
urethral sphincter, presenting with urine loss associated with coughing, sneezing or
increased physical activity (Abrams, 2003; Yokoyama et al., 2004). Radical
prostatectomy patients also experience urine leakage resulting from bladder dysfunction
in the form of overactive bladder and urge incontinence or a combination of bladder
dysfunction and sphincter damage.
Urge Incontinence. Patients who experience involuntary loss of urine
accompanying the sensation of a need to void have urge incontinence. Typically, this is
the result of inappropriate bladder spasms caused by abnormal nerve stimulation
(de Groat, 1997).
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Overactive bladder (OAB) is a syndrome which is characterized by urgency,
frequency and nocturia, and can occur with or without urinary incontinence. The National
Overactive Bladder Evaluation (NOBLE) program surveyed over 5,000 adults across the
United States by age, gender and geographic region to determine the prevalence and risk
factors for OAB. Data from the NOBLE program show that about one third of all
patients with OAB experience urinary incontinence. While both men and women are
equally affected by OAB, overactive bladder with incontinence is more common among
women than men, and the prevalence of both forms increases with age (Stewart et al.,
2003).
Theories related to the pathophysiology of OAB can be described as either
neurogenic or myogenic. Damage along nerve pathways can cause bladder over activity
from uncontrolled voiding reflexes. Stroke or other neurological diseases such as multiple
sclerosis or Parkinson’s disease are often implicated in overactive bladder of neurogenic
origin (Porth, 2011). With myogenic etiology, patients often have bladder outlet
obstruction with an increase in intravesical pressure. Rather than a normal contraction
that can empty the bladder, mini-contractions of the detrusor muscle occur resulting in
overactive bladder symptoms (Wein & Rackley, 2006).
Certain foods, dyes, chemicals, caffeine in any substance, alcohol and tobacco
products have all been implicated as irritants to the bladder wall and are associated with
increased urinary incontinence (Bottomley, 2000).
Mixed Incontinence. Mixed urinary incontinence is a common finding where
patients present with urinary leakage associated with both urgency and physical exertion
(Chu & Domochowski, 2006). Rates of urge and mixed incontinence increase with age,
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while stress incontinence is not significantly associated with age. This may be due, in
part, to age-related diseases that can alter normal urinary function (Wallner et al., 2009).
Other Types of Incontinence. Other common forms of urinary incontinence
include overflow and functional incontinence. Overflow incontinence occurs when the
bladder fails to empty completely, allowing constant dribbling of urine. This can be the
result of a physical obstruction like a urinary stone or enlarged prostate. Overflow
incontinence can also stem from a neurologic abnormality such as a birth defect or spinal
injury or tumor. Functional incontinence is most commonly seen in older adults who
have comorbid or debilitating conditions that may predispose them to urinary
incontinence by limiting their ability to move quickly enough, or to mentally process
their need to urinate or communicate that need to caregivers.
Failure of any aspect of the neuromuscular coordination of micturition can result
in urinary incontinence. The causes of overflow and functional incontinence are very
specific and require management that targets the specific cause. However, pelvic floor
weakness, poor vesicourethral support, and detrusor instability are of great interest with
regard to the application of ExMI because of the potential for this technology to
strengthen the pelvic floor musculature and reduce detrusor contractility.
Treatment for Urinary Incontinence
Treatment regimens for urinary incontinence vary according to etiology. First, a
determination of the kind of urinary incontinence is made by obtaining a thorough history
including food and fluid intake and voiding diaries, as well as physical examination to
assess for pelvic floor abnormalities. Urodynamic studies may also be performed at this
time to help determine bladder and urethral function. Once the underlying cause and the
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severity and type of urinary incontinence is determined, management techniques and
treatments can begin.
Patients are first taught behavioral techniques such as fluid, diet, and bowel
management, Kegel exercises, and in some cases, scheduled voiding or double voiding.
Kegel exercises, sometimes referred to as pelvic floor muscle training, helps to strengthen
and tone the muscles of the pelvic floor and support the urethra so that when there is an
increase in intraabdominal pressure, as with a cough or sneeze, or the patient experiences
an involuntary detrusor contraction, he or she can contract the pelvic muscles so that
urine leakage is prevented (Huebner et al., 2011; Ramundo & Davis, 2002). This training
must be consistently practiced every day and may take months before any benefit is
discernible.
Food/fluid intake diaries and voiding diaries provide valuable information that is
helpful in assessing voiding patterns and leakage. Many foods can irritate the lining of
the bladder resulting in pain, bladder spasms, and urinary incontinence. The volume of
fluid is as important as the types of fluids that patients drink. Drinking excessively as
well as drinking too little can provoke bladder spasms and leakage. These diaries are
simple to use and can give the patient, as well as the practitioner, insight into triggers that
may be causing incontinence. Once the patient has become aware of the relationship
between intake and incontinence, they can modify their diet to help reduce wetting
episodes.
Bladder innervation and function is very similar to rectal innervation and
function. Research has shown that there is a positive correlation between constipation
and bladder dysfunction (Kim, Lee, Jung, & Lee, 2011). Patients who present with

16
urinary incontinence frequently have chronic constipation (Bannister, Lawrence, Smith,
Thomas, & Read, 1988) therefore; bowel management is a critical first step in
conservative treatment of urinary incontinence. Patients are taught how to prevent
constipation and improve bowel function. Many find that it does help to reduce
incontinent episodes.
Kegel exercises and dietary, fluid and bowel management plans require
motivation and daily adherence, but can be very effective for some patients. If these
behavioral management therapies are inadequate, however, more invasive treatment
regimens may be required and are often used in combination with behavioral techniques.
The use of a pessary, an intravaginal device that supports the bladder neck, when fitted
properly can be helpful in preventing stress urinary incontinence in some patients
(Keyock & Newman, 2011).
Electrical stimulation has been used successfully for many years to force
contractions in an effort to strengthen or relax pelvic floor muscles and is often combined
with biofeedback. However, electrical stimulation of the pelvic floor requires the
insertion of probes in the vagina or rectum, and it is not well accepted by patients because
it is invasive and uncomfortable. Adjusting the frequency (Hertz or Hz) of the electrical
stimulation allows the practitioner to force contractions that will either strengthen and
build up muscle or relax muscle. The ability to relax muscle is helpful in patients who
experience detrusor instability of OAB where the bladder contracts without provocation.
Relaxing the bladder helps to lessen leaking episodes in patients who have incontinence
associated with overactive bladder. Electromagnetic stimulation through the use of ExMI
offers the same results without pain, without probes or embarrassment, making it an
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attractive alternative. Studies have extrapolated treatment parameters from traditional
electrical stimulation treatments of the pelvic floor. Frequencies of 5 to 20 Hz have been
reported to inhibit detrusor contractility (Bradshaw, Barker, Radley, & Chapple, 2003);
whereas frequencies of 20 to 50 Hz have been reported to increase intraurethral pressure
which is effective in preventing stress incontinence (Fujishiro et al., 2000; Yamanishi,
Yasuda, Suda, & Ishikawa, 1999).
Magnetic Field Therapy. The use of magnets for the treatment of various
disorders is not a new idea. They are discussed in ancient Chinese and Egyptian writings
from as early as 2000 B.C. Fifteenth century Swiss alchemist, Paracelsus investigated the
use of magnets to heal illness (Macklis, 1993) by restoring the body’s natural energy
(Philpott & Kalita, 2000). Eighteenth century physician and astrologer, Franz Mesmer
believed in an energy that flowed through the body that he called animal magnetism
(Macklis, 1993). Both Paracelsus and Mesmer treated individuals by passing magnetized
stones called lodestones over the bodies of those seeking to be healed (Philpott & Kalita,
2000). For centuries, magnets were widely used to treat illness and restore health, but as
medicine became more grounded in scientific evidence and therapeutic regimens
included effective medications, the use of magnet therapy began to wane. For most of
the twentieth century, magnets were viewed with skepticism and associated with
quackery (Philpott & Kalita, 2000).
While there have been anecdotal reports that static magnets have been helpful in
treating various medical conditions, there is little clinical or experimental data to support
these claims. On the other hand, the use of magnetic energy is readily accepted by both
the medical community and general public for diagnostic imaging with MRI (Lalande et
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al., 2004). Pulsed electromagnetic field therapy has been reported to help a wide variety
of medical conditions including bone healing (Garland, Adkins, Matsuno, & Stewart,
1999; Kumar et al., 2005; MacKenzie & Veninga, 2004; Massari, Fini, Cadossi, Setti, &
Traina, 2006), and soft tissue healing (Kenkre, Hobbs, Carter, Holder, & Holmes, 1996;
Strauch et al., 2006; Yamaguchi, Ogiue-Ikeda, Sekino, & Ueno, 2006). This technology
has also been shown to affect neural tissue (Goodwin, 2003; Mert, Gunay, Gocmen,
Kaya, & Polat, 2006), ease pain (Lyskov et al., 2005; Pipitone & Scott, 2001; Shupak et
al., 2006; Weintraub & Cole, 2004, relieve mental depression (Baeken et al., 2009;
Fitzgerald, Hoy, Daskalakis, & Kulkarni, 2009; Vanderhasselt, DeRaedt, Leyman, &
Baeken, 2009) and help individuals with urinary and fecal incontinence (Galloway et al.,
1999; Thornton, Kennedy, & Lubowski, 2005; Yokoyama et al., 2004; Yokoyama et al.,
2005).
Pulsed Electromagnetic Fields. The application of a pulsed electromagnetic field
is a non-traditional, non-invasive form of energy medicine that is gaining popularity in
healthcare today. The application of a magnetic field is thought to be beneficial by
positively affecting physiological processes. Magnetic therapies can be further divided
based on whether a static magnet or pulsing electromagnet is used. A static magnet is one
that creates a field that moves in a steady flow. An electromagnet can reverse direction
generating a pulsed electromagnetic field when turned off and on rapidly.
The therapeutic application of pulsed electromagnetic fields is based on Faraday’s
Law of Magnetic Induction which asserts that a changing magnetic field will produce
electrical current in adjacent tissues (Walker, 2004). When the changing magnetic field is
generated near living tissue, electrical currents induced within the tissues cause
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depolarization in motor nerves. The ensuing nerve impulse stimulates the release of
acetylcholine, depolarization of muscle fibers and muscle contraction (Galloway, ElGalley, Sand, Appel, Russell, & Carlan, 1998; Hoscan, et al., 2008; Voorham-Van der
Zalm, Pelger, Stiggelbout, Elzevier, & Lycklama A Nijeholt, 2006). No electric current
actually enters the body. The magnetic field is indifferent to tissue impedance. With no
opposition, the magnetic field encounters no obstruction from clothing or human tissue.
Patients who receive pulsed electromagnetic field therapy targeting the pelvic floor
muscles do not need to undress. There is no need for probes or insertion of internal
devices. They sit, fully clothed, on a chair with the electromagnet imbedded within the
seat. When the electromagnet is engaged, the pulsing magnetic field painlessly induces
contractions of the pelvic floor and sphincter muscles (Chandi, Groenendijk, & Venema,
2003; Doganay, Kilic, & Yilmaz, 2010). Termed extracorporeal magnetic innervation
(ExMI), this forced exercise of the pelvic floor serves to build endurance and strengthen
the muscles supporting the bladder during times of physical stress such as coughing,
sneezing or increased physical activity. Another advantage of this treatment is based on
the fact that magnetic stimulation of sacral nerve roots is insufficient to induce bladder
contractions. Studies have demonstrated that when magnetic stimulation is applied,
bladder contractions are inhibited, suppressing detrusor instability in patients with urge
incontinence (Bradshaw, Barker, Radley, & Chapple, 2003; Bycroft, Craggs, Sheriff,
Knight, & Shah, 2004; Voorham-VanDerZalm, Pelger, Stiggelbout, Elzevier, &
Lycklama A Nijeholt, 2006).
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Summary
The purpose of this study was to evaluate the clinical outcomes involving the use
of pulsed electromagnetic fields in the treatment of urinary incontinence. This study is
based on scientific concepts including the physiology of micturition and the science of
pulsed electromagnetic fields. The use of pulsed electromagnetic fields in the treatment
of urinary incontinence is relatively new and there is little in the literature with regard to
this therapy’s efficacy and long-term effects. This study will add to that body of
knowledge related to the effectiveness of ExMI.

CHAPTER II
REVIEW OF THE LITERATURE
The application of pulsed electromagnetic fields has been used for treating a
number of disorders that range from bone and tissue healing to the treatment of
incontinence. This chapter presents an overview of literature related to the effects of
pulsed electromagnetic fields on biological tissues, and includes information on how this
technology has been studied as a modality to treat a variety of conditions including
urinary incontinence.
Stress Urinary Incontinence
Galloway, El-Galley, Sand, Appell, Russell, and Carlan (1999) reported using
pulsed electromagnetic field stimulation to treat stress urinary incontinence in women.
Participants completed 3-day bladder diaries in which they recorded their voided
volumes, the number of leaks they experienced each day, and the number of pads they
used in a day. They also had a standardized pad weight test and urodynamic study to
assess the severity of their leakage. Additionally, all women completed a quality of life
survey. A total of 83 females with stress urinary incontinence were exposed to the pulsed
field by sitting on a chair that had been fitted with an electromagnet under the seat. This
particular piece of equipment is called the Neocontrol System by Neotonus, and has been
FDA approved for the treatment of stress urinary incontinence in women (Galloway et
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al., 1999). The therapy has been named ExMI for extracorporeal magnetic innervation.
The women were completely clothed and seated on the chair so that the perineum was
centered and the pelvic floor muscles were in the direct line of the magnetic field.
Treatments were given twice a week for six weeks. They included ten minutes of pulsed
stimulation at 5 Hz, a 1 to 5 minute rest period, and then ten minutes of pulsed
stimulation at 50 Hz. Every two weeks the patients kept a three-day bladder diary. Two
weeks after the end of the study, all women repeated all baseline studies. At week 12, the
bladder diary and quality of life survey only were repeated. There were 50 women at
follow-up in 3 months. The reduction in pad use was significant (p=0.001) from baseline
to completion of treatment, as was the reduction in frequency of leaking episodes
(p=0.001). Mean bladder capacity was unchanged. Detrusor instability had been
demonstrated in five patients during urodynamic examination at baseline, but only in one
patient after treatment. This is of interest because detrusor instability is associated with
involuntary bladder contraction either spontaneously or on provocation (Chapple &
Christmas, 1992) which results in urge incontinence.
A study by Hoscan et al. (2008) evaluated the long-term efficacy of
electromagnetic stimulation for stress incontinence. Thirty subjects completed bladder
diaries, pad weight tests, urodynamics and quality of life surveys prior to receiving
treatment sessions lasting 20 minutes, twice a week, for six weeks. They received the
same protocol as previously discussed studies with frequencies of 5 and 50 Hz
intermittently for 10 minutes. Follow-up was performed at 3, 12, and 24 months after
treatment. At 3 months, the cumulative success rate was 77.8% with only six subjects not
showing any improvement in symptoms. After one year, researchers report the effect of
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electromagnetic stimulation gradually decreased until subjects’ symptoms were near
baseline at the 24 month follow-up. They concluded that while this therapy offers an
effective modality for urinary incontinence that is painless and non-invasive, more
studies need to be done to determine how long benefits would last and when retreatment
would provide the best outcome.
Bakar, Ozdemir, Ozengin, & Duran (2010) explored the efficacy of ExMI for
older women who were diagnosed with stress urinary incontinence. Thirteen patients
between the ages of 61 and 69 (mean 65.23 + 2.8 years) participated in this study.
Urinary symptoms, pelvic floor electromyographic activity (EMG), pad testing and
Quality of Life (QOL) were evaluated at baseline and at six weeks. Pad test results
showed significant reduction in urine loss (p=0.016), significant improvement in EMG
values (p=0.005) and in QOL scores (p=0.002). This study suggests that ExMI could be
a viable treatment alternative for older women who do not wish to have definitive
surgical intervention or who might not be good surgical candidates.
Ismail, Forward, Bastin, Wareham, Emery, & Lucas (2009) conducted a
prospective, non-controlled study specifically to assess efficacy, side effects, and dropout
rates for women treated with ExMI for stress urinary incontinence. Forty-eight patients
were recruited and outcome measures of pad weight test, daily pad use, daily leaking
episodes and quality of life were evaluated. Thirty-one patients completed eight weeks of
twice weekly treatments. Twenty-seven patients returned at the three month reevaluation. This study revealed no significant differences in outcomes for pad weight,
pad use, leaking episodes or quality of life from beginning to end of treatment or at the
three month reassessment. When asked about side effects the majority of patients

24
(62.7%) cited various types of pain. Eight percent of patients who dropped out of the
study cited various types of pain, and 15% of dropouts gave no reason. This study is
unique in that it looks at side effects and dropout rates, something that has not been found
in other studies.
Detrusor Instability with Incontinence (Urge)
Choe, Choo, & Lee (2007) studied forty eight women with detrusor instability
using the Neocontrol chair and the same protocol as in previous studies. They reevaluated
these subjects at 2, 12, and 24 weeks post treatment and found that subjects’ perception
of treatment benefit and overall satisfaction was 68.8% and 66.7% at week 2, 58.3% and
54.2% at week 12, and 54.2% and 52.1% at week 24. Their study demonstrated that
electromagnetic stimulation therapy has a beneficial effect that can be sustained for an
extended period of time in persons with detrusor instability.
Mixed Urinary Incontinence
Yamanishi et al. (2000) conducted a pilot research study and a therapeutic study
to evaluate efficacy of pulsed electromagnetic stimulation on urethral closure and bladder
inhibition. The pilot study consisted of 11 subjects with stress incontinence and 11
subjects with urge incontinence. The urethral pressure differences between on and off
phases of electromagnetic stimulation showed that maximum urethral closure pressure
significantly increased (p=0.0409) after stimulation for subjects with stress incontinence.
Also, there was a statistically significant increase in bladder capacity at first desire to
void (p=0.0164) and maximum desire to void (p=0.0208) during stimulation for subjects
with urge incontinence.
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In the therapeutic arm, 15 subjects, seven with stress incontinence and eight with
urge incontinence were studied. Urodynamic testing was performed on each subject
before and after a five week treatment regimen with the electromagnetic stimulation.
These subjects recorded frequencies of voiding, leaking, degrees of urgency, pad changes
as well as their perceptions of the therapy and their quality of life scores. At the end of
the study, six of the subjects with stress incontinence and six of the subjects with urge
incontinence indicated that they were either cured or had significant improvement in their
symptoms. Quality of life scores were significantly improved after the treatment regimen
(p=0.0033) with most respondents reporting that they were delighted or mostly satisfied
with their overall quality of life.
These researchers assert that although the outcomes of electromagnetic
stimulation are similar to those of electrical stimulation of the pelvic floor,
electromagnetic stimulation is superior due to the fact that it does not cause pain and it is
noninvasive.
Unsal, Saglam, and Cimentepe (2003) looked at one year follow-up for patients
who had received ExMI for both stress and urge incontinence. The researchers evaluated
clinical outcomes by voiding diary documentation of leaking episodes and pad weight as
well as increase in mean valsalva leak point pressure in patients who had stress
incontinence. At the one year follow-up, patients who reported no leaking episodes and
less than 1 gram urine in pad weight test were documented as cured. Patients who
reported greater than 50% in reduction of leaking episodes and pad weight tests were
documented as improvement. They began with a total of 57 female patients. Of these
patients, 35 were diagnosed with stress and 17 with urge incontinence. Forty-four
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patients completed treatments and returned for follow up in one year. Of the 44 patients,
11 (38%) with stress and 6 (41%) with urge were deemed cured. In addition, there was an
improvement in symptoms in 12 patients (41%) in the stress group and 7 (47%) in the
urge group. Pad weight was reduced from 15.4 to 5.8 g in the stress group and from 12.4
to 4.7 g in the urge group (p = 0.000 and 0.001, respectively). Mean Valsalva leak point
pressure was increased from 87.3 + 15.9 to 118.0 + 11.0 cmH2O in the stress group
(p = 0.000).
Yokoyama et al. (2004) conducted an almost identical study as the one by
Galloway et al. (1999) however; they were interested in exploring whether this therapy
would be effective in treating urge incontinence. These researchers used the same
Neocontrol System chair in their study. Twenty patients with urge incontinence and
seventeen patients with stress urinary incontinence were recruited for this study and
although the results were not as dramatic as for stress incontinence alone, episodes of
leaking were reduced from 5.6 times per day before treatment to 1.9 times per day at 8
weeks (p<0.05) and the mean pad weight was reduced from 7.9 g at baseline to 1.9 g at 8
weeks (p<0.05). Twenty-four weeks after the last treatment, eight patients with urge
incontinence and three with stress incontinence experienced recurrence.
Almeida, Bruschini, and Srougi (2004) studied 91 women using the Neocontrol
chair. These subjects were treated for 20 minutes twice a week for eight weeks. The
treatment protocol consisted of 10 minutes of intermittent low frequency stimulation for 5
seconds at 5 Hz and 5 seconds off, then 10 minutes of intermittent high frequency
stimulation for 5 seconds at 50 Hz and 5 seconds off. The researchers note that subjects
experienced significant improvement midway through the study. By the end of the study,
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they report 34 of the 91 were totally dry with no leaking episodes. These subjects were
followed by interview at 3, 6, and 12 months after the study. The recurrence rate was
high at 47%, 61.7%, and 94% respectively. These researchers conclude that the 16
sessions are not adequate for long-term success since the benefits were temporary with
high and early recurrence rates.
Doganay, Kilic, & Yilmaz (2009) evaluated the long term efficacy of ExMI over
three years. They followed a similar protocol as Unsal, Saglam, & Cimentepe in 2003,
but they added number of pads used daily and Quality of Life (QOL) score as part of
their evaluation of clinical outcomes. In the stress incontinence group, there was a
significant reduction in pad use between the baseline (3.2 + 1.6) to first (2.4 + 1.2),
second (2.9 + 1.17), and third (3.0 + 1.1) year follow-ups (P < 0.001, P > 0.05, P>0.05,
respectively). There was no difference in pad use between the second and third year
follow-ups. In the urge incontinence group where baseline daily pad use was
3.7 + 1.9, the numbers at first, second, and third years were 2.4 + 1.3, 3.1 + 1.8, and 3.3 +
2.4, respectively. Quality of Life scores for patients with stress incontinence improved
from baseline 62.5 to 88.7 at eight weeks which was significant (p=0.001). Quality of
Life scores for patients with urge incontinence saw a similar improvement from baseline
at 60.8 to 86.3 at eight weeks (p=0.001). Patients were evaluated at 12, 24, and 36 month
intervals. The effects of ExMI and QOL scores gradually decreased and were close to
baseline at the 3rd year mark. This suggests that ExMI can provide temporary relief from
urinary incontinence and short-term improvement in quality of life and patient
satisfaction. More understanding of how to extend the benefits of this treatment is
needed.
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Lo, Tseng, Lin, Liang, Lu, and Pue (2013) conducted a retrospective review of 93
patients with stress urinary incontinence and overactive bladder (OAB) who were treated
with ExMI. Results revealed that 72 patients (77%) completed a 9 week protocol of 10
Hz followed by 50 Hz. Thirty-two of 34 patients (94%) experienced improvement for
OAB and 33 of 38 patients (86.8%) experienced improvement of for stress urinary
incontinence. Urogenital Distress scores and Quality of Life scores improved for both
groups. Researchers cite cost of treatment and geographic location as reasons for the
high dropout rate among patients.
Post Prostatectomy Incontinence
A study to compare the effect of pulsed electromagnetic stimulation and electrical
stimulation on urinary incontinence in patients who had retropubic radical prostatectomy
(Yokoyama et al., 2004) showed rapid improvement in symptoms with both methods.
Subjects were randomly assigned to receive electrical stimulation, electromagnetic
stimulation, or be in the control group. The electromagnetic stimulation protocol was the
same as used in previous studies employing the Neocontrol system. The electrical
stimulation protocol used an anal electrode that delivered stimulation at parameters
consistent with electrical stimulation standards for urinary incontinence therapy (Barroso,
Ramos, Martins-Costa, Sanches, & Muller, 2005; Moore, Griffiths, & Hughton, 1999;
Nakagawa et al., 2010). The control group only performed pelvic floor muscle exercises.
After one month, the control group showed slight improvement over electromagnetic or
electrical stimulation groups, but by the second month there was a statistically significant
decrease in incontinence volume in both treatment groups. The researchers consider both
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methods to be viable, recommendable options for patients who seek improvement of
urinary incontinence after radical prostatectomy.
Yokoyama et al. (2005) investigated the effects of pulsed electromagnetic field
stimulation on urinary incontinence after retro-pubic radical prostatectomy. Ten men
who had suffered from urinary incontinence for at least 12 months post radical
prostatectomy were enrolled into the study. Urodynamic studies were performed at
baseline and again at the completion of treatment. The researchers used the same
Neocontrol System as in previous studies to induce the pulsed electromagnetic field.
Patients received treatments for 20 minutes, twice a week for two months. The pulsed
field was set at 10 Hz for 10 minutes, then at 50 Hz for 10 minutes. Bladder diaries, pad
weight testing and quality of life surveys were obtained at one, two, three, and six months
after the start of treatment. Results showed that three patients became dry (30%), three
patients showed improvement (30%), and 4 patients showed no change (40%). Mean pad
weight decreased from 25 g to 10.3 g, and the quality of life scores improved from 70.5
to 84.9. The frequency of leak episodes in a day was reduced from five times prior to the
treatment to 1.9 times after the treatment. Three of six patients who showed
improvement, however, did return to baseline values within a year of treatment, and
requested to be allowed to continue the treatment.
Terzoni, Montanari, Mora, Ricci, and Destrebecq (2012) compared pelvic floor
muscle exercises (PFME) and ExMI for the management of post-prostatectomy urinary
incontinence. Eighty seven patients were treated with PFME, 23 patients were treated
with ExMI, and 22 patients refused intervention and served as the control group. Both
interventions improved scores on the International Prostate Symptom survey and ExMI
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demonstrated faster reduction in symptoms than PFME. Most of these researchers were
rehabilitation nurses and they proposed that ExMI could be an effective treatment
administered and managed by nurses. They suggest that ExMI could be used to quickly
increase pelvic floor muscle strength and that PFME could be used to help patients
maintain that level.
Fecal Incontinence
Thornton, Kennedy, & Lubowski (2005) conducted a study to determine the
effect of pulsed electromagnetic stimulation on anorectal function and physiology. They
studied ten subjects with fecal incontinence, and compared those findings with five
subjects who were continent. Subjects received pulsed electromagnetic stimulation by
sitting in the Neocontrol Chair as discussed in previous studies. The protocol of 10 Hz
for 10 minutes followed by 50 Hz for 10 minutes was followed for this study. The results
revealed that stimulated anal pressures were significantly increased when compared to
resting pressures (p=0.005). After six weeks of treatment, there was a statistically
significant increase in resting pressures (p=0.007), in squeeze anal pressures (p=0.008),
and a decrease in continence scores (p=0.017). Although statistically significant, there
was only a small increase in the subjects’ perceived improvement after six weeks of
treatment.
Studies examining pulsed electromagnetic fields effects on pelvic muscles for
urinary and fecal incontinence suggest that this technology can be beneficial to patients
who have voiding and anorectal dysfunction. More research is needed to determine who
will benefit the most from this therapy, as well as optimal settings and timing duration of
treatment.
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Bone and Tissue Healing
Garland, Adkins, Matsuno, and Stewart (1999) examined the effects of pulsed
electromagnetic fields on osteoporotic bone at the knees of six males with spinal cord
injury. Bone density of both knees was assessed at baseline, 3, 6, and 12 months. One
knee was stimulated with a pulsed electromagnetic field while the other knee served as
the control. Electromagnetic stimulation was conducted for a period of six months. At
three months, during the middle of the treatment period, bone density increased in the
knees that received the stimulation by 5.1%, but declined in the knees that served as
control by 6.6% (significant at p<.05 and p<.02, respectively). At six months, bone
density had returned to near baseline and at 12 months both knees had lost bone density
with the stimulated knees being 2.4 % below baseline, and the control knees being 3.6%
below baseline. This would suggest that pulsed electromagnetic field therapy could be
helpful in slowing down the progression of osteoporosis, but raises questions about the
length of time needed to obtain therapeutic effects and how long positive effects can be
sustained once treatment has ended.
In a study by Massari, Fini, Cadossi, Setti, and Traina (2006) 66 patients (a total
of 76 hips) with early to late osteonecrosis of the femoral head were treated with pulsed
electromagnetic field stimulation for eight hours a day over a period of five months.
Although the researchers considered whether or not the patients were able to avoid hip
replacement surgery to be the ultimate goal of this study, they also compared diagnostic
images taken of the hips at the beginning of the study and at the time of follow-up.
While fifteen hips did require total hip replacement, the number of patients not requiring
hip replacement was significant. All patients were experiencing pain when they entered

32
the study, but by the sixtieth day of treatment, thirty-five patients declared that they were
pain free. Another seventeen patients admitted that pain was only of moderate intensity.
The researchers concluded that pulsed electromagnetic field stimulation may help to
protect the cartilage and bone by reducing inflammation and edema. They hypothesized
that long-term use might actually stimulate bone growth where it is necrotic, thereby
preventing fracture and bone collapse. However, this hypothesis has yet to be tested in
humans.
MacKenzie and Veniga (2004) report in a case study how pulsed electromagnetic
field stimulation was successfully used to reverse delayed union of an anterior cervical
fusion. Their patient was a 43 year old female who presented with complaints of a
clicking noise when turning her head, difficulty swallowing and a feeling of choking at
times. She also complained of shooting pains from her neck to her lower back and
numbness in her upper arms and hands. An MRI revealed severe disc degeneration from
C5 through C7. They performed surgery by removing the diseased disks and placed
allograft bone dowels in the C5-C6 and C6-C7 interspaces secured with an anterior
fixation plate. This patient reportedly had an uneventful recovery and was asymptomatic
for about six months. At her one year postoperative visit she complained of an ache in
her neck that had been getting worse over the past 6 months. X-rays were obtained and
revealed that while bone had formed around the C5-C6 level, the bone graft had failed at
the C6-C7 level. Rather than return to surgery, the patient chose to wear a pulsed
electromagnetic field stimulator for three hours every day for ten months. After three
months, the neck pain had completely resolved, and X-rays taken after fifteen weeks of
stimulation revealed that fusion of the bone graft at the C6-C7 level was beginning to
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take place. At the end of treatment, diagnostic imaging showed solid bone formation at
the C6-C7 level. MacKenzie and Veninga also reported that at the time of their published
case study, which was thirteen months post-treatment, the patient was still asymptomatic
and pain free.
Kenkre, Hobbs, Carter, Holder, and Holmes (1996) studied electromagnetic
therapy as an adjunct to conventional compression dressings in venous leg ulcers. Their
study was a randomized, double blind clinical trial with nineteen patients who had been
diagnosed with venous leg ulcers. They looked at several outcomes including the rate
and scale of wound healing, quality of life, reported pain levels, and degree of mobility.
Patients were randomly assigned to either the active treatment or placebo groups. Active
treatment groups received pulsed electromagnetic stimulation at either 600Hz or 800Hz.
A machine that was indistinguishable from the actual stimulator was used for placebo
treatment. Patients received 30 minute treatments for 30 days. Upon completion, they
were observed and received the standard compression dressing changes only for the next
four weeks. They were assessed on treatment days 1, 5, 20, and 30 and a final
assessment was performed on day 50. The researchers found that the majority of patients
(68%) reported improvement in the size of their ulcers, with 21% of the patients
experiencing complete healing. Relief of pain during the trial was significant (p<0.05).
Patients who received treatment at 800Hz experienced significant healing (p<0.05) when
compared to either the placebo group or the active group that received treatment at
600Hz.
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Perception of Pain
Lyskov et al. (2005) conducted a study on the effect of pulsed electromagnetic
fields on reported pain level, heart rate, and blood pressure in 24 healthy volunteers. This
was a double blind, crossover design study where the subjects served as their own
controls. Twelve males and 12 females each received infusions of 5% hypotonic saline
solution into the erector spinae muscle to induce muscle pain. This experiment was
performed twice, at least two days apart. One time the subject was exposed to the pulsed
field, and one time to a sham field. Results revealed that blood pressure elevation due to
pain occurred during both active and sham exposures, and there was no statistical
difference for heart rate. The study did, however, demonstrate gender differences as
exposure to the pulsed field increased the subjective pain levels in females, but not in
males. This has implications for future investigations into the use of pulsed
electromagnetic fields for the treatment of chronic pain especially with regard to gender
differences in the perception of pain.
Pipitone and Scott (2001) performed a randomized, placebo-controlled, doubleblind study on the effect of pulsed electromagnetic field therapy with 75 patients with
osteoarthritis of the knee. Patients completed the WOMAC Osteoarthritis Index and the
EuroQoL (EQ-5D) at baseline and again after treatment to assess pain, joint stiffness,
disability, and quality of life. There were significant improvements in the actively treated
group on the WOMAC global score (p=0.018), WOMAC pain score (p=0.065),
WOMAC disability score (p=0.019), and EQ-5D quality of life score (p=0.001). These
results suggest that pulsed electromagnetic field therapy could be beneficial in improving
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quality of life by reducing pain and disability for patients who suffer with osteoarthritis of
the knee.
Weintraub and Cole (2004) used a one-group experimental design study to
examine the effect of pulsed electromagnetic fields on refractory neuropathic foot pain in
24 patients who had been diagnosed with peripheral neuropathy. Among these patients,
the one with the most symptomatic foot received nine daily 1-hour treatments with
exposure to the pulsed electromagnetic field at 30Hz. All 24 patients (24 feet) completed
the 9 day study and 15 of the 24 completed follow-up. Mean pain scores decreased 21%
from baseline to end of treatment (p=0.19), but there was a 49% reduction in pain from
baseline to follow-up which was significant (p<0.01). This study suggests that pulsed
electromagnetic field therapy could be useful in providing pain relief for persons
suffering with neuropathic pain.
Shupak, McKay, Nielson, Rollman, Prato, and Thomas (2006) investigated the
use of pulsed electromagnetic fields on pain and anxiety in patients with fibromyalgia
and rheumatoid arthritis. The researchers used a double blind, randomized, placebocontrolled design. Eighteen patients had fibromyalgia, and 13 patients had rheumatoid
arthritis. They received either the pulsed electromagnetic field therapy or sham exposure.
The results revealed that there was no significant reduction in anxiety ratings for either
group. However, there was significant (p<0.05) reduction in pain for the patients who had
rheumatoid arthritis, and significant (p<0.01) reduction in pain for patients who had
fibromyalgia when they were exposed to the active therapy.
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Mental Depression
Pulsed electromagnetic fields have most recently been investigated for treatment
of resistant mental depression. Baeken et al. (2009) studied a small group of subjects
who had been diagnosed with treatment-resistant depression. All subjects were free of
antidepressant and psychotropic medication prior to and during the study. A psychiatrist
rated the subjects’ depression symptoms and depression severity before and after
application of transcranial magnetic stimulation. Forty-three percent of the subjects
experienced a reduction of at least 50% of their depression scores.
A study by Fitzgerald, Hoy, Daskalakis, and Kulkarni (2009) examined the
differences between the application of high frequency transcranial magnetic stimulation
and low frequency transcranial magnetic stimulation. They determined that both
treatment groups showed significant improvements in their depression and there were no
significant differences between the use of high or low frequencies. This is an important
study because there have been very few investigations that compare the efficacy of the
two methods.
Vanderhasselt, DeRaedt, Leyman, and Baeken (2009) discovered similar effects
when depressive symptoms improved in more than half of their therapy-resistant subjects
after receiving transcranial magnetic stimulation.
There is much conjecture as to how transcranial application of pulsed
electromagnetic fields improves mental depression. It has been suggested that it works by
triggering action potentials which cause the neurotransmitters dopamine and serotonin to
be released. Researchers have theorized that the magnetic stimulation alters cerebral
blood flow as well as improves mood by altering brain waves (Baeken et al., 2009;
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Huerta & Volpe, 2009). Results of preliminary studies are promising, but more research
is needed.
Summary
Pulsed electromagnetic field therapy is a painless, non-traditional, non-invasive
modality that holds incredible promise for patients who have not responded to traditional
treatment methods or who may not be good candidates for surgery or other medical
procedures. Currently FDA approved for the treatment of stress urinary incontinence and
muscle rehabilitation, studies suggest that this technology can stimulate cell growth,
improve peripheral perfusion and reduce pain. Because this is a relatively new area of
medicine, there is not a large body of information available. Reported results are varied
and there is little data on the long term effects of pulsed electromagnetic field therapies.
More research is needed to add to the knowledge base of electromagnetic stimulation as a
treatment modality.

CHAPTER III
METHODOLOGY
This chapter describes the methodology that was used in this study. Purpose,
objectives, design, sample, data collection, and data analysis are discussed.
Study Design
This study is a descriptive, retrospective analysis of data collected from a
specialty continence center within a major Atlanta metropolitan outpatient facility. All
patients who were treated with extracorporeal magnetic innervation (ExMI) from 2000
through 2012 were included. Sample size was projected to include 75 to 100 patients;
however the sample size was much smaller with a total of 43 patients who received
ExMI. The purpose of this study is to examine the demographic, clinical and behavioral
factors that support the effectiveness of ExMI treatment for patients with urinary
incontinence. The following objectives are explored:
1. Examine the differences in selected demographics (age in years, gender,
weight in pounds) and relationship among health behaviors (dietary/fluid
management, bowel management), medications (diuretics, central nervous
system [CNS] depressants, hormones, anticholinergics, antihistamines, others
as appropriate to bladder function), physical findings (cystocele, rectocele,
uterine prolapse, vaginal/rectal tone/grip), medical history (length of
incontinence, pelvic surgery, cardiovascular disease, hypertension, diabetes,

39
neurologic disorders, stroke, COPD/asthma, bladder/kidney infections,
pelvic/abdominal/back pain, pregnancies, methods of delivery, and number of
pads used per day prior to treatment), between patients with stress, urge, and
mixed urinary incontinence.
2. Explore the relationship of selected demographics (age in years, gender,
weight in pounds) and health behaviors (dietary/fluid management, bowel
management), medications (diuretics, central nervous system [CNS]
depressants, hormones, anticholinergics, antihistamines, others as appropriate
to bladder function), physical findings (cystocele, rectocele, uterine prolapse,
vaginal/rectal tone/grip), medical history (length of incontinence, pelvic
surgery, cardiovascular disease, hypertension, diabetes, neurologic disorders,
stroke, COPD/asthma, bladder/kidney infections, pelvic/abdominal/back pain,
pregnancies, methods of delivery, and number of pads used per day prior to
treatment), and post-treatment pad usage following ExMI treatment for
urinary incontinence.
3. Describe the patients who returned for additional ExMI treatments.
4. Describe any benefits received unrelated to reduction of urinary incontinence.
Sample
Data was collected on all patients who received treatment with ExMI at this
center from 2000 through 2012 totaling 43 patients. These patients were diagnosed with
stress, urge, or mixed urinary incontinence as well as fecal incontinence, pelvic pain and
urinary frequency and urgency. Data from both female and male patients who received
ExMI was collected, however, the number of females was higher than males. This was
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expected since, statistically, urinary incontinence is more prevalent among middle aged
and older adult females than among males (Huang et al., 2006; Melville, Katon, Delaney,
& Newton, 2005). Exclusion criteria for this treatment included pregnancy, diagnosis of
pelvic cancers, and having a cardiac pacemaker or other implanted metal device. Due to
the overall small number, manual medical record chart review was performed in order to
capture all patients who had completed this treatment.
An online power analysis (Soper, 2012) using a maximum of eleven variables, a
medium effect size, alpha of <0.05 and power of 0.80 determined that a minimum sample
size of 122 patients will be needed. As previously stated, this is a fixed sample size
predetermined by the number of patients at this site who were treated with ExMI. Not all
independent variables are expected to have a significant relationship to the dependent
variable, and so it is anticipated that the number of variables actually entered into the
analysis model will be less. A statistical consultation and adjustment will be made as
necessary to support the power of the findings.
Site
Study data was obtained from patient records of a specialty continence center
within a major Atlanta metropolitan outpatient facility. This center manages about 2000
patients a year who are diagnosed with incontinence. There are differing data in the
literature regarding the prevalence of urinary incontinence among the general population.
According to the National Association for Continence (NAFC), women comprise
approximately 75%-80% of the population who suffer with urinary incontinence (NAFC
facts and statistics) while Melville, Katon, Delaney, and Newton (2005) report that 45%
of the population who have some form of urinary incontinence are women.
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Approximately 75% of the patients treated for urinary incontinence within this center are
women and approximately 25% are men.
IRB Approval
Dr. Niall Galloway, MD, is the medical provider for these patients and primary
prescriber of ExMI treatment. He has been involved with original research related to the
use of ExMI for urinary incontinence and has granted permission for the use of the data
(Galloway et al., 1999). Letters of support from the medical center’s Institutional Review
Board ( IRB) and Dr. Niall Galloway granting permission to access records and perform
research at the center pending IRB approval can be found in Appendices A and B
respectively. The study received approval from Georgia State University’s IRB. The IRB
at the medical center where data was obtained deemed that IRB approval was not
required since the study did not meet the definition of research with “human subjects”
(Appendix C).
ExMI Treatment Protocol
Patients sit fully clothed on a chair designed with a magnetic field generator
imbedded in the seat. This generator is connected to an external power control panel that
controls the pulse current that the patient receives. The practitioner who administers the
treatment can either manually adjust the amplitude and strength of the magnetic field, or
as in most cases, insert a “smart card” into the control panel. The control panel reads the
prescription imbedded in the “smart card” and automatically administers the treatment to
the patient. The standard treatment protocol prescription administers 10 minutes of
intermittent low-frequency stimulation (15 Hz), followed by rest (no stimulation) for 2
minutes, and ends with 10 minutes of intermittent high-frequency stimulation (40 Hz).
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These treatments are administered twice a week for 8 weeks (Galloway et al., 1999;
Hoscan et al., 2008).
There is little in the literature related specifically to ExMI therapy, but among
these studies, there is varied information regarding side effects. Some studies have
reported that patients complained of pain, tingling, abdominal cramping and muscle
fatigue after receiving stimulation (Groenendijk et al., 2008; Ismail et al., 2009) while
other studies report no complaints of discomfort (Galloway et al., 1999; Hoscan et al.,
2006; Yamanishi et al., 2000). Only one study cited reasons for dropping out. These
reasons included pain, urinary tract infection, no improvement and inability to keep
appointments (Ismail et al., 2009). Given the fact that the treatment is administered twice
a week for eight weeks, the time commitment and ability to travel to the clinical site
could certainly have an impact on the dropout rate.
Measures
The following variables were obtained from the medical records and used to
explore the relationship between demographics, medical history, health behaviors,
physical findings, and clinical outcomes. The information was transferred to a data
collection sheet designed for this purpose (Appendix D). This investigator collected the
data while at the center and under the supervision of Dr. Galloway. No patient identifiers
were on the data collection sheets.
Demographics. The following are categorized as demographics: age in years,
gender, and weight in pounds. These characteristics are important because the literature
points to a relationship between age, gender, and weight and the prevalence of urinary
incontinence. Women are more likely to suffer from urinary incontinence than men
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(Keyock & Newman, 2011). Excess weight strains the muscles of the pelvic floor
(Smith, 2004). In longitudinal, population based studies, obesity has been associated
with increased incidence of urinary incontinence (Subak, Richter, & Hunskaar, 2009).
Medical History. The health information relevant to a medical history for
patients with urinary incontinence include the following: length of incontinence,
incontinence diagnosis (stress, urge, mixed), number of pads used per day, number of
pregnancies, method of delivery (vaginal, C-section, both), presence of
pelvic/abdominal/back pain (yes/no), presence of pelvic organ prolapse (yes/no), history
of pelvic surgery (yes/no), history of diabetes (yes/no), cardiovascular disease (yes/no)
hypertension (yes/no) and stroke (yes/no), COPD/asthma (yes/no), bladder/kidney
infections (yes/no) , neurologic disorders (yes/no), and specific medications.
Classifications of medications that are of primary interest include diuretics, central
nervous system depressants, hormones, anticholinergics, and antihistamines. Other
medications that can affect bladder function will also be noted.
Urinary incontinence and pregnancy, process of childbirth and method of delivery
have been strongly associated and documented in the literature (Foldspang, Mommsen, &
Djurhuus, 1999; Rortveit, Hannestad, Daoltweit, & Hunskaar, 2001; Wesnes, Hunskaar,
& Rortveit, 2009). Research suggests that prolonged stages of labor and delivery have
more of an impact on post-natal urinary incontinence than method of delivery; however
data for post-natal urinary incontinence after C-section are inconclusive. In this study the
number of pregnancies and methods of delivery will be noted as vaginal, C-section, or
both.
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Muscles and ligaments cradle and support the pelvic floor structures of the
bladder, urethra, vagina and uterus. Excessive stress on these muscles and ligaments
from overweight, birth trauma, prolonged heavy lifting, and chronic coughing cause
weakness that can result in pelvic organ prolapse. Patients who have had a hysterectomy
are also at risk for prolapse as the uterus acts as a support structure for the pelvic floor.
When the uterus is removed, an important support is also removed so there is an
association between pelvic organ prolapse and urinary incontinence (Luft, 2006; Serati et
al., 2011; Smith, 2004).
The literature suggests that urinary incontinence is prevalent among individuals
with chronic medical illnesses such as cardiovascular disease and diabetes (Boyd et al.,
2011; Lee, Cigolle, & Blaum, 2009; Lifford, Curhan, Hu, Barbieri, & Grodstein, 2005;
Phelan et al., 2009; Rosso et al., 2011). Neurologic bladder control with successful urine
storage and emptying is the result of coordination between the parasympathetic and
sympathetic nervous systems. Patients with neuropathology, whether congenital or
acquired, are at risk for urinary incontinence. Patients who have urinary tract infections
can experience urinary incontinence when the irritated bladder causes urgency and
frequency. Illnesses, infection and neuropathic disorders will be noted and summed.
Some medications like diuretics, central nervous system depressants, hormones,
anticholinergics and antihistamines have shown the potential to impact bladder function
and may result in urinary incontinence (Keister & Creason, 1989). This researcher is
interested in whether or not a patient takes medication (yes/no) from any of the selected
drug classifications. However, the dosing regimens are not of interest in this study. The
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number of the classifications of medications (from 0 being none to the number they are
using) that patients are taking will be summed for the medication variable.
Health Behaviors. Conservative therapies that help to manage urinary
incontinence will be included as health behaviors; these include diet and fluid
management, bowel management and Kegel exercises. Use of conservative therapies
will be reported as yes (1) or no (0). The types of therapies the patients participate in will
then be summed with scores ranging from 0 (none) to 3. Data regarding the use of
conservative therapies will be reported, before ExMI treatment and during ExMI
treatment. For patients who repeat ExMI treatment, use of conservative therapies post
ExMI will also be noted.
Physical Findings. Several physical findings may be associated with urinary
incontinence. These include cystocele, rectocele, and uterine prolapse, vaginal/rectal
tone and grip. Cystocele and rectocele are herniations of the bladder and rectum in to the
vagina. This occurs when there is weakening of the pelvic floor muscles. Uterine
prolapse is the dropping of the uterus into the vagina which results when the ligaments
that support the uterus are overstretched. Vaginal and rectal tone and grip are indicators
of pelvic floor muscle strength. These physical findings are discovered during the
medical examination and are noted in the patients’ records on the Continence Center
Intake Form. Cystocele, rectocele, and uterine prolapse are described as no (0) or yes (1)
and if yes, its station with respect to the introitus: slight (1), to introitus (2), beyond
introitus (3). Vaginal/rectal tone is described as normal (1) or abnormal (0) and grip is
described as sustained (1) or not sustained (0).
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Pressure and pain in the pelvis, lower abdomen and lower back are common
complaints for patients with pelvic organ prolapse; (Lau, Weinstein, Wakamatsu,
Macklin, & Pulliam, 2013; Reddy, Barber, Walters, Paraiso, & Jelovsek, 2011). The
literature suggests that ExMI may have an ameliorating effect on pain. Pain is assessed
prior to beginning ExMI treatment and will be recorded as no (0) or yes (1).
Clinical Outcomes
Urinary incontinence was measured by the dependent variable, number of pads
used per day, as reported by the patient. The number of pads used in a day was noted at
the beginning and end of treatment and. For patients who returned to repeat the protocol,
the number of patients as well as how long (how many weeks) between treatment
protocols was included in clinical outcomes. The number of pads used in a day are
compared from beginning to end of treatment and are markers that are frequently used to
determine if a treatment for urinary incontinence has been successful. There is very
limited literature related to the effect of ExMI on pad usage or wetting episodes, but one
multicenter study of ExMI for stress incontinence revealed that pad usage was reduced
from 2.5 to 1.3 per day (p=0.001) and the number of wetting episodes was reduced from
3.3 to 1.7 (p=0.001) per day (Galloway et al., 1999).
Any reports of benefits unrelated to reduction in incontinence are also included in
clinical outcomes. The literature indicates that the application of pulsed electromagnetic
fields has therapeutic benefits including pain relief, increased blood flow, and tissue
healing. For this reason, any patient-reported benefits unrelated to improvement in
incontinence are included and described.
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Procedure
Once institutional review board (IRB) approval was obtained from Georgia State
University and the healthcare system where data was collected, a list of all patients who
received ExMI treatment was provided through the offices of clinical research for the
urology department and health information management. Because electronic records
were not available for these patients, archived records were reviewed.
A data collection sheet (Appendix D) was created to hold all data abstracted from
the medical records. Each record was assigned a study number that was used instead of
patient names. A key code sheet with information that could link the study number with
the patient was stored separately from the data to protect privacy. All study information
is stored in a locked file cabinet owned by this researcher. Names or other facts that could
identify the patients will not appear when the study is presented or when results are
published.
Design and Data Analysis
A descriptive, retrospective, secondary analysis of medical records was
performed. Frequencies and percentages were calculated for gender, diagnosis (stress,
urge, mixed), health behaviors (dietary/fluid management, bowel management),
medications (diuretics, central nervous system depressants, hormones, anticholinergics
and antihistamines), physical findings (cystocele, rectocele, uterine prolapse,
vaginal/rectal tone/grip), medical history (length of incontinence, pelvic surgery,
cardiovascular disease, hypertension, diabetes, neurological disorders, stroke,
COPD/asthma, bladder/kidney infections, pain (pelvic, abdominal, back), pregnancies,
number and methods of delivery, number of patients who repeated the treatment protocol,
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number of pads used per day before treatments and number of pads used per day after the
treatments. Means, standard deviations and ranges were calculated for age, weight and
number of pregnancies. T-tests were performed to examine the differences in
improvement (reduction in pad usage) with respect to age, weight, gender, pain, pelvic
surgery, number of deliveries, and daily pad usage at the beginning of treatment and at
the end of treatment. Analyses of correlation were performed to examine the association
between age, weight, number of pregnancies, number of deliveries and improvement
(reduction in pad usage).
Summary
This chapter has described the purpose, objectives, design, sample, data collection
and data analysis that were used in this study.

CHAPTER IV
RESULTS
The results of a retrospective review of all patients who were treated for urinary
incontinence with ExMI, a description of the sample and a discussion of the research
objectives are presented in this chapter. Research objectives were modified due to
sample size limitations and available information that was documented in the archived
records.
All medical records for patients who received ExMI from 2000 through 2012
were examined. Data was collected on a total of 43 patients. Of those 43 patients, thirtyfive were treated for urinary incontinence. Each of the 35 patients received the same
treatment protocol of 15 Hz for 10 minutes, a two-minute rest period, and 40 Hz for 10
minutes. Each patient received two treatments a week for eight weeks. Eight patients
were excluded for various reasons ranging from receiving ExMI for a condition other
than urinary incontinence to being lost to follow-up. Those patients who were excluded
will be discussed separately.
Sample Characteristics
The mean age of the patients in this study (n=35) was 63.4 years (SD=12.38).
There were 26 (74%) females and nine (26%) males. Of the 26 females, 11 had stress
incontinence, six had urge incontinence, and nine had mixed incontinence. Of the nine
males, five had stress, one had urge and three had mixed incontinence. Eight males were
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treated post- prostatectomy and they had either stress or mixed incontinence. The one
male with urge incontinence had not undergone prostatectomy. See Table 1.
Weight was calculated separately for males and females. One female was an
extreme outlier weighing 416 pounds; her weight was removed from this calculation to
give a more accurate description of this sample. The mean weight for the nine males was
177.6 (SD=26.33) pounds and the mean weight for the remaining 25 females was 140.9
(SD=24.86) pounds. See Table 2.
Table 1
Type of Urinary Incontinence by Gender N=35

Gender

Stress

Urge

Mixed

N

Female

11

6

9

26

Male

5

1

3

9

Gender

N

Range

M

SD

Female

25

112-222

140.9

24.87

Male

9

125-215

177.6

26.33

Table 2
Weight by Gender *N=34

*One female was an extreme outlier at 416 pounds and was removed from this
calculation
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Research Objective 1: Examine the differences in selected demographics (age in years,
gender, weight in pounds) and relationship among health behaviors (dietary/fluid
management, bowel management), medications (diuretics, central nervous system [CNS]
depressants, hormones, anticholinergics, antihistamines, others as appropriate to bladder
function), physical findings (cystocele, rectocele, uterine prolapsed, vaginal/rectal
tone/grip), medical history (length of incontinence, pelvic surgery, cardiovascular
disease, hypertension, diabetes, neurologic disorders, stroke, COPD/asthma,
bladder/kidney infections, pelvic/abdominal/back pain, pregnancies, methods of delivery,
and number of pads used per day prior to treatment), between patients with stress, urge,
and mixed urinary incontinence.
All 35 patients were given instruction for a dietary/fluid management and bowel
management program prior to beginning ExMI. Only one patient admitted to not
following the program while receiving treatment. No statistical calculation was made for
these variables since all patients were placed on this routine.
Patients who were treated with ExMI completed an intake record at their initial
visit to the medical center. In this record patients disclosed medical history, previous
surgeries and listed any medications that they were taking. Forty percent of all patients
were on hormone therapy and approximately 49% of patients were taking
anticholinergics and antihistamines. Medications that could impact bladder function
were recorded and are summarized in Table 3.
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Table 3
Patient Medications
N=35

Medications

Frequency

Percentage

Diuretics

5

14.29

Hormones

14

40.00

Anticholinergics

7

20.00

Antihistamines

10

28.57

CNS Depressants

8

22.86

Part of the medical history included acute or chronic illnesses that could impact
continence, pelvic surgeries, and pain were of interest. Fourteen women had
hypertension, eight had cardiovascular disease and one woman was a diabetic. Of the
men, two had hypertension, two had cardiovascular disease and one was a diabetic.
Neurologic disorders included one patient with Parkinson’s, one patient with cerebral
palsy and hemiplegia, and three patients who had experienced neurological deficits that
required spinal fusion surgeries. Patients who had pelvic surgery included eight men who
had prostatectomies, eleven women who had hysterectomies, one woman who had
bladder suspension and one woman who documented “many pelvic surgeries”. Of the
eight patients who experienced pain, five complained of pelvic pain and three complained
of back pain. Table 4 summarizes medical history with regard to acute and chronic
illness, pelvic surgery and pain.
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Table 4
Medical History: Acute and Chronic Illness, Pelvic Surgeries & Pain
N=35

Condition

Frequency

Percentage

CVD

10

28.57

HTN

16

45.71

Diabetes

2

5.71

Neurologic Disorder

5

14.29

Bladder/Kidney Infection

4

11.43

Pain

8

22.86

Pelvic Surgery

21

60.00

Medical history also included pregnancies and methods of delivery. Most women
had 2 or 3 pregnancies (57%) and delivered vaginally (85%). Two women had both
vaginal and C-section deliveries (10%). Pregnancies and methods of delivery are
presented in Table 5.
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Table 5
Number of Pregnancies and Methods of Delivery
N=26

Number of Pregnancies

Frequency

Percent

0

5

19.23

1

2

7.69

2

10

38.46

3

5

19.23

4

1

3.85

5

2

7.69

6

1

3.85

Vaginal

17

85.00

C-Section

1

5.00

Both

2

10.00

Methods of Delivery

Most patients had experienced urinary incontinence between 1 to 5 years (69%).
When separated by gender, five of nine men (56%) were incontinent for two years or
less, whereas only eight of 26 women (31%) were incontinent for two years or less.
Eighteen women (69%) were incontinent for three or more years. Length of time of
incontinence is presented in Table 6.
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Table 6
Length of Time of Incontinence
N=35

Incontinence

Frequency

Percent

< 1 year

10

28.57

1-2 years

16

45.71

3-5 years

2

5.71

6-10 years

5

14.29

> 10 years

4

11.43

Physical examination findings included 12 patients with cystocele (44.44%), and
11 with rectocele (42.31%). Uterine prolapse was not documented for any of the
patients. Vaginal tone was abnormal in 16 patients (61.54%) with grip not sustained in
23 patients (88.46%). Rectal tone was abnormal in 10 female and 7 male patients
(48.57%) with rectal grip not sustained in 19 female and 8 male patients (77.14%).
Research Objective 2: Explore the relationship of selected demographics (age in years,
gender, weight in pounds), health behaviors (dietary/fluid management, bowel
management), medications (diuretics, central nervous system [CNS] depressants,
hormones, anticholinergics, antihistamines, others as appropriate to bladder function),
physical findings (cystocele, rectocele, uterine prolapse, vaginal/rectal tone/grip), medical
history (length of incontinence, pelvic surgery, cardiovascular disease, hypertension,
diabetes, neurologic disorders, stroke, COPD/asthma, bladder/kidney infections,
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pelvic/abdominal/back pain, pregnancies, methods of delivery, and number of pads used
per day prior to treatment), and post-treatment pad usage following ExMI treatment for
urinary incontinence.
Patients documented the number of pads they used daily at the beginning of
treatment and again at the end of treatment. Before treatment, 37% of patients used one
to two pads daily, but 63% of patients used three to five pads daily. After treatment, 31%
of patients were no longer using pads, 54% had reduced daily pad usage to one or two
and only 14% were using three or four pads daily. Daily pad usage at the start of
treatment and at the end of treatment is summarized in Table 7.
Table 7
Pad Usage
Pad Usage Before
Treatment

Frequency

Percentage

Cumulative
Percentage

1

4

11.43

11.43

2

9

25.71

37.14

3

13

37.14

74.29

4

7

20.00

94.29

5

2

5.71

100.00

(Table 7 Continues)
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(Table 7 Continued)

Pad Usage After
Treatment

Frequency

Percentage

Cumulative
Percentage

0

11

31.43

31.43

1

14

40.00

71.43

2

5

14.29

85.71

3

2

5.71

91.43

4

3

8.57

100.00

Patient outcome was measured by comparing the pad usage before treatment and
at the end of treatment (16 weeks). A paired t-test was performed to examine the
difference between daily pad usage in the beginning and at the end of treatment. Results
in this study were significant (t(34)=10.23, p<.0001) with the average number of pads
used daily being reduced to 1.63 + 0.94. All but six patients saw improvement in urinary
incontinence with the reduction of daily pad use (83%). No patients experienced an
increase in urinary incontinence or an increase in pad usage. The improvement in the
number of pads per patient is shown in Table 8.
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Table 8
Improvement by Number of Pads

Number of Pads

Patients

Percent

0

10

28.57

1

16

45.71

2

2

5.71

3

5

14.29

To examine the difference in age and weight between those who had
improvement (reduction in pad usage) and those who did not, an independent t-test was
performed (Table 9). There was no evidence that the average age for those who improved
was any different than for those who did not improve (t(33)=0.31, p=0.7606); also no
evidence that the average weight for those patients who improved was any different than
for those who did not improve (t(33)=1.62, p=0.1154).
Table 9
Improvement with Regard to Age and Weight
Variable
Age

Weight

Improvement

N

Mean

SD

No

6

64.83

8.93

Yes

29

63.10

13.09

No

6

189.7

115.7

Yes

29

151.7

29.02
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With regard to gender (Table 10) using the independent t-test, no statistical
difference in improvement (reduction in the number of pads used daily) was noted
between males or females (t(33)= -0.67, p=0.5045) .
Table 10
Average Improvement (reduction in number of pads) for Males and Females

Gender

N

Mean

SD

Male

9

1.44

1.01

Female

26

1.69

0.93

There was no significant difference in improvement for patients who experienced
pain (M=1.25, SD=1.17) and those who did not experience pain (M=1.74, SD=0.86;
t(33)=1.31, p=0.2000). Patients who had undergone pelvic surgery (M=1.76, SD=0.10)
and those patients who had not undergone pelvic surgery (M=1.43, SD=0.85;
t(33)=-1.03, p=0.312) did not differ in improvement.
When looking at frequencies for improvement by diagnosis, 16 patients (100%)
with stress incontinence, 5 patients (71%) with urge incontinence, and 8 patients (67%)
with mixed incontinence reported improvement (reduction in pad usage). Because the
sample was small, a Fisher’s Exact Test was performed. While patients with stress
incontinence experienced overall greater reduction in pad usage than patients with urge or
mixed incontinence, the results were not statistically significant (p=0.2328).
Frequencies for improvement by length of time of incontinence revealed that 29
patients (83%) experienced improvement by reduction in pad usage by 1 to 3 pads a day.
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Nineteen of these patients (54%) had been incontinent for three or more years. Although
clinically interesting, the overall improvement by length of time of incontinence was not
statistically significant (p=0.8743).
Frequencies for improvement by patients who had previous pelvic surgery
indicated that 29 patients (83%) experienced improvement by 1 to 3 pads a day.
However, six patients who also had previous pelvic surgery had no reduction in pad
usage. Overall these results were not significant (p=1.000) indicating that having pelvic
surgery did not result in a significant reduction in pad usage.
Pearson product moment correlations were performed to assess the relationships
between improvement and the variables of age, weight, number of pregnancies, and
number of deliveries. One patient’s weight was in excess of 400 pounds. This outlier’s
data was removed from the analysis. No correlations were found between improvement
and age (r=0.038, n=35, p=0.827), improvement and weight (r=-0.0188, n=34, p=0.288),
improvement and number of pregnancies (r=0.203, n=26, p=0.320), or improvement and
number of deliveries (r=0.01, n=23, p=0.9666).
Research Objective 3: Describe the patients who returned for additional ExMI
treatments.
Four patients repeated the treatment protocol. These returning patients were all
females with a mean age of 64 (SD=12.19) and mean weight of 133 pounds (SD=13.14).
Two of the women had mixed incontinence, one had stress and one had urge
incontinence. All four of the women had been pregnant (a total of 15 pregnancies) and
three had delivered vaginally; only one had delivered by Cesarean. All were instructed to
follow the same fluid/dietary management and bowel management program that they had
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used during the first treatment protocol. It is not known if these patients had continued
the fluid and bowel program after they completed the first treatment protocol to the time
of their return or if they had stopped using those conservative techniques. The length of
time between protocols varied significantly. One patient returned after nine months, one
returned after two years, one after three years and one after six years. Two of the patients
were using two pads daily when they began the second protocol and after the eight weeks
treatment had reduced to zero pads. The other two patients began with three pads a day
and reduced to one pad a day. All returnees had good results and none of the returnees
came back for a third treatment protocol.
Eight patients were excluded for various reasons. Of the eight patients who were
omitted, five were males and three were females. Of the eight patients who were
excluded from the study, one was a female who had severe paravaginal defects and who,
after four weeks of treatment, discontinued care to have surgery. One was a female who
had a rectovaginal fistula as a result of birth trauma. She received eight weeks of
treatment, but did not have improvement in fecal incontinence and had surgical repair of
the fistula. The other two patients attended for two weeks receiving a total of four
treatments, but failed to keep any additional appointments and were lost to follow-up.
Research Objective 4: Describe any benefits received unrelated to reduction of urinary
incontinence
Four patients benefited from ExMI unrelated to urinary incontinence. All four of
the patients were males with a mean age of 58.5 (SD=8.39) and mean weight of 180.75
(SD=26.03). One patient had undergone colon cancer surgery and radiation which
resulted in rectal and pelvic floor spasms with occasional fecal leakage. This patient
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received a treatment prescription of 50 Hz for 10 minutes followed by a two minute rest
period and an additional 50 Hz for 10 minutes twice a week for eight weeks. With a high
frequency setting at 50 Hz the muscles of the pelvic floor are unable to contract and
relax, and instead there is a tetanic contraction. This setting is most commonly used in
electrical stimulation devices for alleviation of pain. At the completion of 16 weeks, this
patient reported that the pain had become less constant and more manageable.
The second patient who had pain and fecal incontinence had undergone
cystoprostatectomy and creation of an orthotopic neobladder. He presented with fecal
incontinence, pelvic pain, erectile dysfunction and urinary incontinence from the
orthotopic neobladder for which he wore condom catheters. This patient also received a
prescription of 50 Hz for 10 minutes followed by a two minute rest period and an
additional 50 Hz for 10 minutes twice a week for eight weeks. By the end of his
treatments this patient reported “significant improvement” in his pain as well as in the
fecal incontinence. There was no appreciable improvement in the urinary leakage,
however, and the patient continued to wear condom catheters.
The third patient presented with scrotal and rectal pain, and irritative symptoms of
urinary frequency and nocturia, but no urinary incontinence. This patient’s medical
history was significant for cervical spine defects with radiculopathy and cervical
spondylosis, left hip neuropathy and sleep apnea. He had been managing his pain with
gabapentin and amitriptyline. His prescription was the standard 15 Hz for 10 minutes, a
two minute rest period, and 40 Hz for 10 minutes. This patient completed the eight week
regimen of treatments and reported that he had received relief from pain and urinary
frequency within the first few visits.
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Diagnosed with interstitial cystitis (IC), the final patient received treatment for
pain, urgency, frequency and nocturia. There were no surgeries documented for this
patient and his only history beside IC was atrial fibrillation and hypertension. His
medications included Atenolol and Elmiron which he had taken for IC for two years.
After the standard prescription for eight weeks this patient reported pain, urgency,
frequency and nocturia had improved.
Summary
The characteristics of the study sample and the results of data analysis related to
the research objectives were presented in this chapter. While there was a total of 43
patients who received this treatment, 35 patients were treated solely for urinary
incontinence. Most of the patients were women (n=26, 74%) and most patients had stress
urinary incontinence (n=16, 46%) or mixed urinary incontinence (n=12, 34%). Patient
outcome was measured by comparing the pad usage before treatment and at the end of
treatment (16 weeks). The average number of pads used daily was significantly reduced
from 2.82 + 1.15 to 1.6 3 + 0.94 (p<.0001). Testing to evaluate comparisons and
correlations for other variables within the research objectives did not demonstrate
statistical significance.
Excluded from the central study, two patients with pelvic pain and fecal
incontinence and two patients with pelvic pain alone received treatment for their
respective conditions with ExMI. All four patients reported improvement in their
symptoms. Although rating scales are commonly used in reporting pain levels, only
subjective reports of symptom relief were available for these patients. When considering
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quality of life, even a small improvement in pain or reduction in episodes of fecal
incontinence could be considered clinically significant by that patient.

CHAPTER V
DISCUSSION
In this study, clinical outcomes for patients who received Extracorporeal
Magnetic Innervation therapy for urinary incontinence were examined. This chapter
presents a discussion of study findings as well as limitations and implications for nursing
practice.
The goal of ExMI treatment is to strengthen the pelvic floor muscles to the
extent that when the patient laughs, coughs or sneezes, they can engage those muscles
and prevent urine leakage. The clinical outcomes of a retrospective study of patients
receiving ExMI treatment are presented below.
Sample
A total of 43 patients received ExMI from 2000 through 2012. Of those 43
patients, 35 were treated for urinary incontinence and were included in this study. The
eight remaining patients were treated for conditions other than urinary incontinence or
were lost to follow-up; those cases are discussed separately.
Of the 35 patients, 26 were females and nine were males. That women were
disproportionately represented in the sample is supported by the literature that maintains
more women than men experience urinary incontinence (Katz, 2009; Moore & Gray,
2004; Riss & Kargl, 2011). This is an expected finding since previous studies that
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explored ExMI for urinary incontinence also recruited more women than men
participants unless the study was specific to male incontinence post-prostatectomy.
Most of the patients would be considered to fall within the older adult category.
Although the age range of the sample was 21 to 91 years, the mean age was 63.4 years
(median=64 years). This is an expected finding and is supported by the literature (Bakar,
Ozdemir, Ozengin, & Duran, 2010; Moore & Gray, 2004). In aging adults, normal
physiological changes such as loss of tissue elasticity or general weakening of pelvic tone
can result in urinary incontinence. Prostate enlargement is a common cause of voiding
problems in older men and atrophic changes in the vagina and urethra as a result of
decreased estrogen levels is a common problem in older women.
Prior to, throughout, and following ExMI treatment, all patients were instructed to
follow a fluid/dietary management plan instructing them to avoid bladder irritants such as
caffeine, highly acidic foods and juices, carbonated drinks and artificial sweeteners.
Patients were also instructed to drink adequate fluids (six to eight 8-ounces) daily. While
some patients might overindulge in liquids, most patients who have experienced
incontinent episodes will reduce their daily fluid intake to prevent incontinent episodes.
Concentrated urine alone can cause irritating symptoms which can increase urgency,
frequency and leakage. By avoiding bladder irritants the patient may be able to remove
the stimulant that contributes to urinary frequency, urgency and leakage. In addition, all
patients were instructed to begin a bowel program using a fiber supplement and, if
necessary, a stool softener to effectively empty their bowel and keep it empty. The bowel
and bladder communicate through neural pathways that allow for normal function. If the
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bowel is sluggish and the patient becomes constipated, the bladder also receives the
message, resulting in urinary dysfunction. Patients who present with urinary incontinence
are often troubled with chronic constipation. While this is not an indication of major
neurologic disease, it demonstrates the neurologic link between bowel and bladder
function. Although compliance with this fluid/dietary/bowel management plan is
important to the success of ExMI treatment, statistical testing was not performed on this
variable since all patients were placed on these routines and reported adherence to the
regimen.
Many of the patients in this study were on medications for various medical
conditions which could have an effect on bladder function. Diuretics are known to
increase urgency, frequency and urinary output. Commonly prescribed for patients who
have cardiovascular problems or hypertension, five patients were taking diuretics. The
CNS depressants, anticholinergics, and antihistamines can all cause urinary retention by
either relaxing the bladder or increasing bladder outlet resistance. Eight patients were
taking CNS depressants, seven patients were taking anticholinergics, and 10 patients
were taking antihistamines. It was not documented as to whether the patients were taking
these medications to help them manage their incontinence or if they were on the
medications for some other reason. Fourteen patients were taking hormones. Used to
improve the condition of vaginal and urethral tissues, hormonal replacement, either oral
or topical can be very helpful in the treatment of urinary incontinence. Most of the
patients in this study were older women, so it was a reasonable finding that 40% of the
patients were on hormone replacement. There were no changes in medications
documented from pre to post treatment.
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In reviewing past medical history among the patients in this study, it was not
surprising to find that cardiovascular disease and hypertension were very prevalent since
these conditions are prevalent among the general aging population. The risk of
cardiovascular disease increases for women past menopause due to the loss of estrogen.
Indirectly, the medications for these conditions, such as diuretics, may be implicated in
incontinence. Previous pelvic surgery which included hysterectomy and prostatectomy
were also prevalent among these patients. For females, the removal of the uterus alters
pelvic floor support and can predispose the patient to leakage of urine. In men, the
prostate gland offers some mechanical protection from incontinence. Prostatectomy
removes that barrier.
Five of the eight patients in this study who complained of pain experienced pelvic
pain. Pelvic pain is a common complaint, but the origin of the pain may not be obvious
making assessment and treatment difficult. Pelvic floor laxity with subsequent prolapse
of the bladder or rectum, damage to the pudendal nerve related to birth trauma (Hompes,
Jones, Cunningham, & Lindsey, 2010) and pelvic floor spasm related to prolonged
sitting, pelvic surgery or traumatic vaginal delivery (Swisher, Rich, & Weiss, 2012) have
all been implicated.
Physical examination findings revealed that most women in the study had some
degree of pelvic floor dysfunction which includes cystocele and rectocele. Abnormal
vaginal or rectal tone and non-sustained grip were common findings in the sample as
well. Although these conditions are implicated in urinary incontinence, the sample was
too small to show a relationship between these variables and the outcome. Detailed
physical examination findings were not documented for the final (post treatment) visit.
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Approximately 69% of all patients in this study had experienced urinary
incontinence between one and five years and nearly 29% had been living with
incontinence ranging from six to over ten years. Based on the information that was
available, this researcher could not determine if these patients had tried and failed in their
efforts to resolve their urinary incontinence prior to coming to this center. It is difficult
to predict when someone will seek care for incontinence. Lack of knowledge about the
disorder and what can be done for it rank high among reasons that patients cite for
delaying medical care. Patients may feel that incontinence is just a normal part of aging
that must be tolerated or they may fear treatment or medication that might be prescribed
for them and the side effects they may cause. Because incontinence is not a life
threatening disorder, patients tend to ignore the symptoms until they are no longer
tolerable and negatively impact other aspects of their lives. Primary care providers or
specialists who care for these patients and help them manage other medical problems
usually do not ask their patients if they experience urinary incontinence. Initiating the
conversation about incontinence with their patients might be helpful in removing the
stigma associated with it and encourage more patients to seek help earlier.
Pregnancy and childbirth subject the muscles and ligaments of the pelvic floor to
stretch and overload. The gravid uterus takes up space and adds pressure to the
surrounding structures. Pregnancy has been likened to “being in a constant state of
increased weight bearing” (Smith, 2004, p. 132). When the delivery takes place,
stretching and tearing of the pelvic floor tissues occur. Episiotomies are performed to
limit tearing, but cutting through the perineum and posterior vaginal wall to assist in
delivery still traumatizes the pelvic floor. According to the CDC, Cesarean births
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reached an all-time high in the United States in 2009, but have leveled off since that time
(Osterman & Martin, 2013). Cesarean deliveries are performed for various, complex
reasons that may be medically necessary or may be controversial and performed for
convenience or to limit liability. The patients who were included in this study were
pregnant and delivered prior to the time period when Caesarian sections were on the rise.
Most of the women in this study who were pregnant had either two or three pregnancies
and the majority (85%) of all pregnancies ended in vaginal delivery. While there is a
train of thought that Cesarean delivery can help to protect the structure and stability of
the pelvic floor, maintaining continence in later years, this has not been definitively
validated in the literature. Only one patient in this study had a single Cesarean delivery
and two patients had both vaginal and Cesarean deliveries. It is this researcher’s opinion
that this finding reflects obstetrical practices at the time of their deliveries and does not
suggest that women who have Cesarean births experience less incontinence than women
who have vaginal births.
In looking at the diagnoses of stress, urge or mixed incontinence, most of the
patients experienced either stress or mixed incontinence. Stress incontinence is urinary
leakage resulting from an increase in intra-abdominal pressure as would occur when
coughing, laughing or with increased activity like lifting or running. Urge incontinence
is the result of an overactive bladder that prompts a strong, sudden need to urinate. Urge
incontinence is generally the result of neurological dysfunction or irritative symptoms.
Mixed incontinence is a combination of both stress and urge. In the general population,
the prevalence of both stress and mixed incontinence is greater than the prevalence of
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urge incontinence alone (Nitti, 2001) and the findings in this sample are consistent with
Nitti’s research.
While there are several ways to measure treatment efficacy, comparing daily pad
counts before a treatment regimen and after a treatment regimen is frequently used as an
outcome marker to define the effectiveness of that treatment and is the method used in
this study. The results in this study were significant (p<.0001) with the average number
of pads used daily being reduced to 1.63 + 0.94. Improvement by reduction in daily pad
usage is consistent with the literature on ExMI (Almeida, Bruschini, & Srougi, 2001;
Bakar, Ozdemir, Ozengin, & Duran, 2010; Doganay, Kilic, & Yilmaz, 2009; Galloway et
al., 1999; Hoscan et al., 2008; Lo et al., 2013; Terzoni, Montanari, Mora, Ricci, &
Destrebecq, 2012; Unsal, Saglam, & Cimentepe, 2003; Yamanishi et al., 2000;
Yokoyama et al., 2004). When looking at improvement and gender, there was no
difference in improvement as measured in reduction of daily pads between males or
females. Theoretically, pelvic floor muscle exercises (PFME) strengthen the muscles to
improve urethral sphincter closure whenever there is an increase in intra-abdominal
pressure. These exercises have long been prescribed for male patients post-prostatectomy
to help them regain continence, however, most of the literature on the efficacy of PFME
focuses on women and not men, and this knowledge may not apply to the complex issues
of incontinence in men. In this study it does appear that the male patients did respond to
ExMI as well as the female patients, suggesting that ExMI is equally effective in the
management of urinary incontinence in men and women.
Age, weight, medical history, pelvic surgeries, pain, medications, length of
incontinence, physical exam findings, pregnancies, deliveries and type of incontinence
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were not significantly associated with the reduction of daily pad usage (outcome) in this
study. Pearson product moment correlation testing did not demonstrate any relationships
between age, weight, number of pregnancies or number of deliveries. Other studies
exploring the efficacy of ExMI have had similar results with regard to influence of study
variables on outcomes. Almeida, Bruschini, & Srougi (2004) explored duration of
incontinence, history of hysterectomy, duration of menopause, BMI, patient age and type
of incontinence and found that these variables had no influence on outcome in spite of
improvement in the reduction of pad usage and improved quality of life for participants in
that study. ExMI studies by Ismail et al. (2009) and Voorham-Van der Zalm, Pelger,
Stiggelbout, Elzevier, and Nijeholt (2006) both cite no significance related to the study
variables and outcomes in their respective studies. A small sample size is the consistent
feature of these ExMI studies and this must be considered as a possible reason why the
variables do not appear to influence outcomes.
In this study there were four patients who repeated the treatment protocol. All
four participants received good results with the first protocol, but urinary symptoms
returned with increased incontinent episodes and pad usage prompting them to return for
an additional series of treatments. With any exercise program, if the exercise stops, the
muscle tone is eventually lost, and this appears to hold true with ExMI. Researchers have
noted that improvement in urinary incontinence peaks during the treatment period, lasts
up to a year, but then degrades. Doganay, Kilic, & Yilmaz (2009) noted how the
majority of patients experienced good results for up to a year after treatment, but then
returned to baseline within three years of completion.
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Patients tend to delay seeking medical care for urinary incontinence until it
becomes a problem that negatively affects other aspects of their lives. It is unclear from
the data if the patients who returned came back for more treatment soon after symptoms
returned or if they waited until the symptoms could no longer be ignored. Knowing this
information could help providers educate their patients about the possibility of needing
additional treatments. The literature has shown that symptoms return a year or more after
treatment ends. What was unique about those patients who did not return? Did they have
sustained symptom relief, or did they choose not to return because the location for
treatment was inconvenient, the treatment was too costly, or some other issue prevented
them from returning? Would “booster” treatments at specific intervals help patients
maintain continence?
Of the eight patients who were excluded from the study, one was a female who
had severe paravaginal defects and who after four weeks of treatment, discontinued care
to have surgery. One was a female who had a rectovaginal fistula as a result of birth
trauma. She received eight weeks of treatment, but did not have improvement in fecal
incontinence and had surgical repair of the fistula. The other two patients attended for
two weeks receiving a total of four treatments, but failed to keep any additional
appointments and were lost to follow-up. There were four patients who received benefit
from ExMI unrelated to urinary incontinence. Two had pelvic pain and two had fecal
incontinence and pelvic pain. All four patients reported improvement in their symptoms.
Previous ExMI studies in which individuals were treated for pain (Lyskov et al., 2005;
Pipitone & Scott, 2001; Weintraub & Cole, 2004; Shupak et al., 2006) and fecal
incontinence (Thornton, Kennedy, & Lubowski, 2005) had shown promise for patients
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with these conditions. While these four patients were not included in the main study,
their response to treatment in light of the literature suggests that ExMI could be
considered as a viable treatment option for patients with pelvic pain and fecal
incontinence.
Study Limitations
The most compelling limitation of this study was the small sample size. Although
the outcome of improvement by reduction of pad usage was significant, the study did not
yield any significant relationships between other selected variables and the outcome. This
could be a result of the very small size of the sample. Because this was a retrospective
chart review, the small size was unfortunate, but unavoidable.
When performing a retrospective record review the researcher must accept the
data that is available and design a study with questions and variables that would be
appropriate to the existing data. Because the data was retrieved from existing patient
records, the details and notes found were not bound by strict guidelines that would be
established when designing a scientific inquiry and may not have included variables that
would be of interest to the researcher. The latter was an issue in this retrospective study.
While the findings may not have been statistically significant with regard to a
number of variables and outcome, it is possible that the patients who received even
modest improvement would consider their outcome to be clinically significant. There
was no way to explore the patients’ perceptions of treatment effectiveness.
Implications for Nursing Practice
Providing conservative therapies for continence care have traditionally fallen
within the realm of nursing. Nurses can provide the education patients need about their
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condition. They can teach patients the conservative measures such as pelvic floor
muscle exercises, fluid management and bowel management that can help them attain
some relief and control over their symptoms, and they can work with the patient’s
provider to manage care and provide treatments as prescribed.
With regard to ExMI, this therapy holds great promise for patients with different
diagnoses and pelvic floor dysfunctions. With the aging of our population, it is
reasonable to expect to see more patients needing continence care who might not desire
or meet the criteria for surgical intervention. Patients today are savvy healthcare
consumers and are open to alternative therapies that can offer improvement without
serious side effects. Patient safety is of prime importance and throughout the literature,
the absence of adverse effects related to the use of ExMI is repeatedly discussed
(Culligan, Blackwell, Murphy, Ziegler, & Heit, 2005; Hoscan et al., 2008; Yamanishi et
al., 2000).
At the present time this therapy is readily available and used extensively in over
80 countries across the globe. Nurses in Italy who care for incontinent patients have the
autonomy to decide if ExMI is right for their patients and to independently provide this
treatment (Terzoni, Montanari, Mora, Ricci, & Destrebecq, 2012). ExMI is prescribed
less often in the United States than it was when it was first introduced, but this has less to
do with treatment efficacy and more to do with availability of the technology, the
problem patients had with getting to and from clinics that had the chair, cost of treatments
and reimbursement issues. The good news is that engineers are looking at a new design
that could address some of those problems and could renew interest in using ExMI in the
United States (personal communication with Dr. N. Galloway).
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Summary
This study has explored the relationships between specific variables and clinical
outcomes involving the use of ExMI in the treatment of urinary incontinence. Results
revealed that patients who received ExMI for incontinence experienced improvement as
evidenced by reduction in daily pad usage that was statistically significant. Age, weight,
medical history, pelvic surgeries, pain, medications, length of incontinence, physical
exam findings, pregnancies, deliveries and type of incontinence were not significant with
regard to the outcome. Charts on all patients who received ExMI from 2000 to 2012
were reviewed. Eight patients who did not meet the criteria for inclusion in this study,
however four of these patients did experience benefits from ExMI treatment for other
clinical conditions than a reduction in urinary incontinence; these cases were also
discussed.
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Appendix D
Data Collection Sheet

Subject ID number

_____ _____ _____

Demographics
Age (in years)

_____

Gender
1. Male
2. Female
Weight (in pounds)

_____

_____

Race/Ethnicity
1. African American
2. Asian/Pacific
3. Caucasian
4. Hispanic
5. Native American
Medical History
Length of time of incontinence
1. < 1 year How many months? _____
2. 1-2 years
3. 3-5 years
4. 6-10 years
5. > 10 years

_____

Diagnosis
1. Stress Incontinence
2. Urge Incontinence
3. Mixed Incontinence

_____

Number of Pregnancies

_____

Methods of Delivery
1. Vaginal
2. C-Section
3. Both

_____

101
Number of Deliveries
1. Vaginal
2. C-Section
3. Both
Pain
No (0)
Yes (1)
Location
1. Pelvic
2. Abdominal
3. Back

_____
_____
_____

_____
_____
Scale 0-10

_____

Disorders
_____Cardiovascular
_____Hypertension
_____Diabetes
_____Neurologic
_____Stroke
_____COPD/asthma
_____Bladder/kidney infections
Pelvic Surgery
_____
1. Yes
Type of surgery: _________________________________
2. No
Health Behaviors
Conservative therapies
Yes (1)
Total Number _____
No (0)
_____Fluid/dietary management
_____Bowel management
_____Kegel exercises
Medications
Yes (1)
No (0)
_____Diuretics
_____CNS depressants
_____Hormones
_____Anticholinergics

Pre

During

Post

____
____
____

____
____
____

____
____
____
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_____Antihistamines
_____Other _____________________________________________
Substance Use
Yes (1)
No (0)
_____Tobacco _____Never smoked
_____Currently smoking
_____Cigarettes per day
_____Cigars per day
_____Pipes per day
_____Smokeless tobacco per day
_____Smoked in the past ________time since cessation
_____Caffeinated beverages
Type___________________________________
______ number per day
_____Alcohol
Type___________________________________
______number per day
Physical Findings
No (0)
Yes (1)

Station with respect to introitus
(1) Slight
(2) To introitus
(3) Beyond introitus

_____Cystocele

_____

_____Rectocele

_____

_____Uterine prolapse

____

Abnormal (0)
Normal (1)

Not Sustained (0)
Sustained (1)

_____Vaginal tone

_____ grip
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_____Rectal tone

_____grip

Urodynamics results ____________________________________________________
Treatment Protocol
Number of Treatments

_____tx week X _____weeks

Prescription

_____Hz_____Min.
_____Min. rest
_____Hz_____Min.

Outcome Measures
First Evaluation Midpoint

Final
Evaluation

Number of Daily
Wetting Episodes
Number of Daily
Pad Use
Repeated Protocol

_____

1. Yes
How long between protocols_____________
Number of Treatments

_____tx week X_____weeks

Prescription

_____Hz_____Min.
_____Min. rest
_____Hz_____Min.

2. No
Repeated Protocol
First Evaluation Midpoint
Number of Daily
Wetting Episodes
Number of Daily
Pad Use

Final
Evaluation

